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ABSTRACT
Acetate, a short-chain fatty acid that plays a key role in all domains of life, can be
utilized as a carbon source or excreted as a product of metabolism. Acetate kinase
(ACK), a member of the acetate and sugar kinase-Hsp70-actin (ASKHA) enzyme
superfamily, is responsible for the reversible phosphorylation of acetate to acetyl
phosphate utilizing ATP as the phosphoryl donor. Acetate kinases are ubiquitous in the
Bacteria, found in one genus of Archaea, and are also present in microbes of the
Eukarya. A partially purified ACK which can utilize pyrophosphate (PPi) as the
phosphoryl donor in the acetyl phosphate-forming direction was previously identified in
Entamoeba histolytica, the causative agent of amoebic dysentery. Here I describe my
research on the E. histolytica PPi-dependent ACK.
My biochemical and kinetic characterization of the E. histolytica ACK revealed
several properties that are unique to this enzyme. First, the E. histolytica enzyme is
capable of utilizing acyl substrates longer than butyrate and can utilize acyl substrates as
long as hexanoate in the direction of acetyl phosphate synthesis. Second, this ACK can
only utilize PPi as a phosphoryl donor and cannot utilize ATP. The kinetic parameters for
substrate affinity indicate that the enzyme prefers both an acetate and propionate in the
acetyl phosphate-forming direction; however, the low kcat raises question whether this
direction of the reaction is physiological. The enzyme operates preferentially in the
direction of acetate/PPi synthesis as the rate of catalysis and overall catalytic efficiency
are 1,102-fold and 240,351-fold higher, respectively. Studies of the mechanism of this
enzyme indicates that the PPi-ACK follows a sequential mechanism, supporting a direct
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in-line phosphoryl transfer mechanism previously reported in the well characterized
Methanosarcina thermophila ATP-dependent ACK .
A modified hydroxamate assay was developed for measuring ACKs in the
direction of acetate formation. A coupled enzyme assay has been used to measure ATP
production in the direction for the prokaryotic ACKs, but there was not a method
available for measuring a PPi-forming ACK in this direction. The assay described here
allowed for the determination of kinetic parameters in the acetate-forming direction for
the E. histolytica ACK and can not only be used to measure ACK activity of both ATPdependent and PPi-dependent acetate kinases in the direction of acetate formation, but
could also prove useful for other enzymes that utilize activated acyl substrates such as
acetyl adenylate and acetyl-CoA.
Investigation of the residues in the putative PPi-ACK active site in E. histolytica
revealed that while residues conserved across the ACK family are present in the active
site, the enzyme has a number of significant active site changes in comparison to its
counterpart, the M. thermophila ATP-dependent ACK. The residues His117, His172, Val87,
Thr201, Thr15, Arg274, and Asp272 appear to be essential for catalysis in the direction of
acetate synthesis. Furthermore, His117 appears to be critically important for binding acetyl
phosphate and therefore important in acetate/PPi synthesis reactions.
RNA interference of E. histolytica ACK was unable to be carried out due to
problems with transfection of plasmid DNA into the parasite. However, data garnered
from cellular extracts indicates that E. histolytica has a PPi-dependent ACK but not ATPdependent ACK. Activities of the eukaryotic ACK partner enzymes
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phosphotransacetylase and xylulose 5-phosphate/fructose 6- phosphate phosphoketolase
were absent in cellular extracts. The absence of bacterial ACK partner enzymes in
Entamoeba suggests that a novel acetyl phosphate generating enzyme is the partner for
the PPi-ACK in this protist. This speculative partner enzyme could generate acetyl
phosphate from an intermediate of the pentose phosphate pathway or the end product of a
yet to be identified catabolic pathway.
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CHAPTER I
LITERATURE REVIEW ON ACETATE KINASE AND THE PARASITE
ENTAMOEBA HISTOLYTICA
I. INTRODUCTION
Acetate, a short-chain fatty acid that plays a key role in all domains of life, can be
utilized as a carbon source or can be excreted as a product of metabolism. The
interconversion of acetate to acetyl-CoA is an important step in a variety of both
catabolic and anabolic pathways and can occur via three pathways. The first pathway
consisting of the enzymes acetate kinase (ACK) and phosphotransacetylase (PTA), is
reversible and nearly ubiquitous in the Bacteria. ACK catalyzes the reversible transfer of
the γ-phosphoryl group of ATP to acetate to form acetyl phosphate [EC 2.7.2.1, Eqn. 1],
PTA then catalyzes the reversible transfer of coenzyme A (CoA) forming acetyl-CoA
[EC 2.3.1.8; Eqn. 2]. A unidirectional ADP-forming acetyl-CoA synthetase (ADP-ACS),
found in amitochondriate protists and some microbes in the Bacteria and Archaea,
catalyzes the conversion of acetyl-CoA to acetate to generate ATP [EC 6.2.1.1.3, Eqn. 3].
Finally, the AMP-forming acetyl-CoA synthetase (AMP-ACS) is widespread in the
Archaea, Bacteria, and Eukarya and is the predominant enzyme for activating acetate to
acetyl-CoA [Eqn. 4].
acetate + ATP ' acetyl-Pi + ADP

[Eqn. 1]

acetyl-Pi + CoA ' acetyl-CoA + Pi

[Eqn. 2]

acetyl-CoA + ADP + Pi → acetate + ATP

[Eqn. 3]

acetate + ATP + CoA → acetyl-CoA + AMP + PPi

[Eqn. 4]
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ACK, a member of the acetate and sugar kinase-Hsp70-actin (ASKHA) enzyme
superfamily, has recently been identified in a number of eukaryotic microbes including
algae and oomycetes, non-yeast fungi, and a few protists including Entamoeba
histolytica. In this chapter, the biochemistry, enzymology, and mechanism of prokaryotic
ACKs are introduced including a thorough discussion of the Methanosarcina thermophila
enzyme, the best characterized prokaryotic ACK. The physiological roles of ACK in the
Bacteria and Archaea are also explored. A brief introduction to E. histolytica, which has
a novel PPi-dependent ACK, is provided with respect to the metabolic processes of the
parasite.
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II. ATP-DEPENDENT ACETATE KINASES
1. Physiological Roles of Acetate Kinase in the Bacteria and Archaea.
ACK, an important enzyme in bacterial metabolism, partners with PTA forming
one of three pathways for the interconversion of acetyl-CoA and acetate [1]. ACK and
PTA are nearly ubiquitous in bacteria which undergo fermentation though the use of the
AK-PTA pathway for energy conservation in the conversion of acetyl-CoA to acetate. In
non-fermentative bacteria, the pathway operates to activate acetate to acetyl-CoA for use
as a carbon and/or energy source. Some bacteria such as Escherichia coli take advantage
of the reversibility of the ACK-PTA pathway (Figure 1.1). The ACK-PTA pathway is
used for acetate activation at high acetate concentrations while AMP-ACS is favored
under low acetate conditions [2, 3]. Under conditions that result in mixed acid
fermentation, acetyl-CoA cannot enter the TCA cycle and excess acetyl-CoA is used to
produce acetate and ATP via the ACK-PTA pathway [1]. Under aerobic conditions the
ACK-PTA pathway is used to excrete acetate and generate ATP.
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Figure 1.1. The acetate switch. Bacterial pathways for acetate fermentation and the
generation of acetyl-CoA are accomplished though an ACK/PTA pathway. Modified
from [1].
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Other enzymes that can generate acetyl phosphate include pyruvate oxidase
(POX), xylulose 5-phosphate/fructose 6-phosphate phosphoketolase (XFP),
sulfoacetaldehyde acetyltransferase (XSC), and glycine reductase (GR). These enzymes
have been shown to function with ACK and are found in a group of diverse bacteria, but
not in E. coli [4]. POX, present in diverse lactobacilli and Streptococcus pneumoniae,
catalyzes the oxidative decarboxylation of pyruvate to acetyl phosphate, carbon dioxide,
and hydrogen peroxide. XFP, present in heterofermentative lactobacilli such as
Bifidobacterium and Lactobacillus species, catalyzes the formation of acetyl phosphate
and glyceraldehyde 3-phosphate (or erythrulose 4-phosphate) from xylulose 5-phosphate
(or fructose 6-phosphate) and inorganic phosphate. XSC, present in several genera of
Proteobacteria, cleaves sulfoacetaldehyde to acetyl phosphate and sulfite. Acetyl
phosphate formed by these enzymes has two possible metabolic fates, either conversion
to acetyl-CoA by PTA for anabolic pathways or conversion to acetate by ACK for ATP
synthesis. GR is an important enzyme involved in the metabolism of glycine in some
strictly anaerobic gram-positive bacteria such as Clostridium and Eubacterium [5].
Sarcosine and betaine reductases, like GR also yield acetyl phosphate as a product. In all
three pathways, energy is formed by the ACK-catalyzed conversion of acetyl phosphate
to ATP.
Only two genera of methane-producing archaea, Methanosaeta and
Methanosarcina, have been isolated that are capable of converting acetate to methane [6].
Methanosaeta is an obligate acetotroph and utilizes AMP-ACS to activate acetate to
acetyl-CoA at the expense of two high-energy phosphates in the first step of
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methanogenesis. Methanosarcina, which can also utilize carbon dioxide, methylated
amines and methylated sulfides as energy and growth substrates [7], employs acetate
kinase (ACK) and phosphotransacetylase (PTA) to activate acetate to acetyl-CoA [1,2].
Methanosarcina is the only genus in the Archaea with ACK or PTA. In both genera,
acetyl-CoA is then cleaved at the carbon-carbon and carbon-sulfur bond by carbon
monoxide dehydrogenase/acetyl-CoA synthetase (CODH). The carbonyl group is
oxidized to carbon dioxide [8, 9] and the methyl group reduced to methane [10].
Electrons derived from CODH are transferred via ferrodoxin and an iron-sulfur
flavoprotein to a membrane-bound electron transport system which may serve to generate
an ion gradient for the synthesis of ATP [10-12].
2. Biochemistry of the Methanosarcina thermophila Acetate Kinase
The native ACK from Methanosarcina thermophila has been purified and
characterized [13]. The presence of high concentrations of acetate kinase in extracts of M.
thermophila cultured on acetate supported the hypothesis that ACK functioned
physiologically in the initial activation of acetate for the conversion to methane and
carbon dioxide [13]. An additional supporting argument was the detected presence of
PTA [14, 15] which would allow the conversion of ACK-generated acetyl phosphate to
be converted to acetyl-CoA [12]. Increased levels of PTA had also been reported when
M. thermophila was grown on acetate [12]. Furthermore, when M. thermophila was
cultured in the presence of methanol or acetate, the synthesis of PTA was not inhibited by
methanol, but was found to be induced by acetate in the growth medium [15].
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The genes encoding the M. thermophila ACK and PTA were cloned and
sequenced [14], and found to be transcribed as a single transcriptional unit with pta
located upstream of ack and separated by an intergenic sequence [16]. Examples of acyl
kinase/PTA genes co-expressed from the same promoter have been previously noted in E.
coli [3] and Clostridium acetobutylicum [17]. The M. thermophila pta-ack operon was
shown to be regulated by growth substrate. Northern blot analyses indicated that the
steady-state levels of the pta-ack transcript were several fold greater in acetate-grown
cells than cells grown on methanol or methylated amines [16]. Consistent with the
transcript studies, the activities of PTA and ACK are at least 8- to 11- fold higher in
acetate grown cells than in cells grown on other carbon and energy sources [16]. The
development of molecular genetics tools such as in vivo transposon mutagenesis in
Methanosarcina acetivorans [18] allowed Rother and Metcalf [19] to demonstrate that
the pta-ack mutants could not grow on acetate as a carbon and energy source. Thus, the
activation of acetate to acetyl-CoA in aceticlastic methanogenesis in Methanosarcina
occurs through ACK and PTA [15].
Noting the high similarity of the M. thermophila and E. coli ACKs, and the
conservation of residues near the active site of those ACKs purified from bacteria,
Latimer and Ferry [14] initiated a preliminary investigation of the active site of the M.
thermophila ACK using a number of amino acid modifying agents. Using
diethylpyrocarbonate (DEPC) and phenylglyoxal, modifiers of histidine and arginine
respectively, they suggested that one or more arginine residues and possibly one histidine
residue were implicated in the active site of the M. thermophila ACK [14]. This
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hypothesis was partially supported by previous evidence of an essential arginine residue
in the active site of the E. coli ACK which could be inactivated by chemical modification
[20]. Further evidence was garnered by Latimer and Ferry [14] using thermal stability
assays by comparing the optimal activity temperatures of the commercially available
ACK from E. coli and the recombinantly produced M. thermophila ACK in order to
further highlight the presence of an essential arginine residues by substrate protection.
Latimer and Ferry [14] were also able to show that binding of ATP induced a
conformational change in the ACK, thereby making the enzyme more stable. When preincubated with 10 mM ATP for 5 minutes, the enzyme retained full activity up to 70°C.
In Tris buffer alone, the enzyme was completely inactive after incubation for 5 minutes at
55°C [14]. Although 10 mM phenylglyoxal resulted in 95% inactivation of enzyme, preincubation with ATP resulted in only 61% inhibition indicating some protection from
inactivation. However, the presence of either acetyl phosphate or acetate did not prevent
the inactivation by phenylglyoxal [14]. This data is consistent with at least one arginine
residue being present in the ATP active site of the ACK [14].
Singh-Wissmann et al. [21] investigated five arginine residues (R91, R175, R241,
R285, and R340) in the M. thermophila ACK which were identified as being highly
conserved among other ACKs. R91 and R241 alanine variants displayed extremely low
specific activities which precluded obtaining kinetic data [21]. Leucine and lysine
alteration to these two amino acid positions resulted in specific activity ranges similar to
the recombinant wild-type, with exception of the R91K variant which was reported to
have a specific activity at the lower limit of detection at 0.5 µmol min-1 mg-1 [21]. While
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considered a conservative replacement for arginine, the R91K variant displayed a kcat of
over 100-fold lower and a Km for acetate nearly 14-fold greater than the wild-type (Table
1.1) which implicated R91 as important for catalysis and binding of acetate [21]. A 100fold decrease in the kcat for ATP and more than 400-fold decrease in catalytic efficiency
by the R91K variant in comparison to the wild-type further implicated the importance of
this residue in catalysis. Replacement of R285 with alanine, lysine, or leucine, resulted in
1% catalytic efficiency of the wild-type. However, an increase of nearly 10-fold in the Km
for acetate for R285 indicated that this residue may be important for acetate binding [21].
Variants of R175 and R340 displayed low activity, but their respective kinetic parameters
were not significantly altered to implicate them in substrate binding or catalysis. Thus,
R91 and R241 are important for catalysis in the M. thermophila ACK and may be
important for acetate binding. With the assistance of crystal structures, Gorrell et al. [22]
later confirmed the importance of R91 and R241 in catalysis.
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Table 1.1. Kinetic Constants of Recombinant Wild-Type and Arginine Variants of M.
thermophila ACK. Taken from [21].
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Previous research on the E. coli ACK [23] had suggested that the mechanism for
the ACK involved a phosphoryl-enzyme intermediate, with an unspecified glutamate
residue phosphorylated. E384, E385, and E97 in the M. thermophila ACK were identified
as having a role in either substrate binding or catalysis (Table 1.2) [24]. E384 variants
had very low or no detectable activity indicating an important role in catalysis.
Replacement of E385 with alanine or aspartate did not significantly alter the kcat, but did
significantly increase the Km values for both acetate and ATP, indicating that E385 is
important for substrate binding, but not catalysis (Table 1.2) [24]. Changes to E97
resulted in decreases in the Km for acetate corresponding decreases in kcat indicating that
this residue may influence acetate binding.
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Table 1.2. Kinetic constants of unaltered and altered ACKs from M. thermophila.

a

Unaltered and altered ACKs were produced in E. coli.

b Published values for the ACK purified from M. thermophila (1) are given.
c

Apparent value.
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In 2001, Buss et al. [25] solved the structure of the M. thermophila ACK and
indicated that it may be the ancestral enzyme of the ASKHA (acetate and sugar
kinases/Hsc70/actin) superfamily. The enzyme contained two domains with a duplicated
βββαβαβα core with insertions of subdomains between elements of the β-sheet [25]. Of
note were the numbers of highly conserved residues known to play a role in the active
sites of other ACKs as well as other members of the ASKHA family. In the active site,
Buss et al. [25] noted the presence of a hydrophobic pocket, composed of R285, I332,
I339. Furthermore, the structure also confirmed the presence of H180 and H123 and the
importance of these residues in binding the phosphate of acetyl phosphate, along with
R91, R241, and G212 [25]. The presence of a sulfate ion in the active site from
crystallization conditions is believed to occupy the site of the phosphate of acetyl
phosphate. The sulfate ion ligands binding to these side chains are conserved within the
acetate kinase-butyrate kinase family [25]. The importance of E384, a residue conserved
among all acetate and butyrate kinases, was shown to be moved into the active site upon
cleft closure, participating in catalysis. Known to be essential for enzyme function [24],
Buss et al. [25] hypothesized that this residue is likely a phosphorylation site for a direct
in-line phosphoryl transfer mechanism.
The role of histidines in the M. thermophila ACK was investigated around the
same time using DEPC inactivation and structure-function studies. When incubated with
increasing concentrations of DEPC, the M. thermophila ACK displayed both a time and
concentration-dependent loss of enzymatic activity [26]. These results suggested the
presence of a number of histidine residues in the active site with at least one residue
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located directly in the active site, as previously suggested by Latimer and Ferry [14].
Ingram-Smith et al. [26] identified a conserved histidine residue H180 as essential for
catalysis and hypothesized that this residue could potentially function as a hydrogen bond
donor or positive charge stabilizer for a pentacoordination transition state for a direct, inline mechanism proposed earlier [27].
Miles et al. [28] further confirmed the importance of E384 on catalysis in the M.
thermophila ACK. A 30-fold increase in the magnesium concentration was required for
half-maximum activity of the E384A variant, implicating this residue in magnesium
binding. Furthermore, D148 and N7 variants resulted in catalytic efficiencies of less than
1% of the native M. thermophila ACK. Miles et al. [28] proposed that the third
stabilization site, required for a direct, in-line phosphoryl transfer mechanism as proposed
by Blättler and Knowles [27], may be a magnesium ion stabilized by E384 and N7, with
R91 and R241 serving as the other two stabilization sites.
Using the solved structure of the M. thermophila ACK, Ingram-Smith et al. [29]
identified a hydrophobic pocket formed by the residues V93, L122, F179, and P232 in
the active site cleft of the enzyme which is hypothesized to serve as the acetate-binding
site (Figure 1.2). Changes to these residues resulted in significant increases in the Km for
acetate (Table 1.3) highlighting the contribution of these residues in acetate binding [29].
Alteration of V93 to alanine and glycine resulted in 14-fold and 26 fold respective
increases in the Km for acetate. The P232A variant displayed a 21-fold increase in acetate
affinity compared to the wild type. Specifically, the identification of the F179 is
important with respect to other members of the ASKHA enzyme family, as this residue is
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conserved in all acetate, propionate, and butyrate kinases [25]. Members of this family
undergo a catalytically-required domain closure [30-32], characterized by the presence of
a glycine residue forming a phenylalanine-glycine pair. This structural architecture,
which has been observed in glycerol kinase [32, 33], hexokinase [34], and
phosphoglycerate kinase [35] was also observed by these researchers [29] in acetate and
propionate kinases. The 233-fold and 99-fold decrease in respective turnover and
catalytic efficiency for acetyl phosphate observed for the F179A variant also highlights
the importance of this residue in the active site [29]. F179 is located at the N terminus of
the helix α3, a bridge between domains I and II with respect to ASKHA superfamily
structures [25].
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Figure 1.2. Structure of the ACK dimer from M. thermophila. Areas in red represent
clefts of the binding pockets. Taken from [25].
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Table 1.3. Kinetic parameters of wild-type and variant ACKs assayed in the direction of
acetyl phosphate
synthesis.
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3. The Catalytic Mechanism of Acetate Kinase
The studies of the catalytic mechanisms of ACKs have been limited to the E. coli
and M. thermophila enzymes. The E. coli ACK was first described by Lipmann in 1944
and finally isolated by Rose [36] in 1954. The majority of research performed on the E.
coli enzyme has been limited to mechanistic studies with the earliest information
concerning the mechanism in 1972. A phosphoenzyme intermediate was generated by
incubating the enzyme with either γ-32P-ATP or acetyl 32P-phosphate [37]. This result
was consistent with the enzyme functioning through a ping-pong mechanism where the
enzyme and ATP reacted to form a phosphoenzyme, and then a phosphoryl transfer from
the phosphoenzyme to acetate to form acetyl phosphate. The phosphoenzyme
intermediate was shown to be capable of phosphoryl transfer to either ADP or acetate
[37, 38]. A caveat to this proposed mechanism was that the substrate exchange rates for
ADP/ATP and acetate/acetyl phosphate were less than the rate of catalysis. In fact, one
report indicated a 7-fold faster ADP/ATP exchange reaction than the reported rate of
catalysis [39]. In the same report, the acetate/the acetyl phosphate rate of exchange was
64-fold slower than the rate of catalysis [39], and a second report indicated no detectable
exchange of acetate/acetyl phosphate [36]. Furthermore, reported slower exchange rates
for acetate/acetyl phosphate in the presence of ATP, culminated in these researchers
inability to exclude that reactions were occurring in both the acetate/ATP and the acetyl
phosphate/ADP directions; and therefore, may not be limited to one particular direction
[40].
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Since the initial mechanistic studies two phosphoryl transfer mechanisms have
been proposed for ACK [22, 41]. In a single displacement mechanism, a direct
phosphoryl transfer occurs from the gamma phosphate of ATP to acetate. In 1980,
Spector [41], based on the evidence of the phosphoenzyme intermediate, proposed a
triple-displacement mechanism where the gamma phosphate of ATP is transferred over
two separate enzyme sites before final transfer to acetate [27]. The reaction would be
characterized by a net inversion of configuration of the phosphorus atom during transfer
from ATP to acetate. While the presence of the phosphoenzyme intermediate had been
previously demonstrated [37], Spector [41] noted that a direct transfer was sterically
problematic; as experimental evidence on tetra- and penta-coordinate phosphorus
compounds had resulted in evidence to suggest one or more SN2-type displacements; with
mechanisms involving steric inversions during each initial and subsequent reaction(s)
[27, 42, 43]. He therefore proposed a triple displacement mechanism for ACK involving
two phosphoenzyme intermediates, and three inversions of the phosphorus (Figure 1.3) to
accommodate the steric and special requirements between the substrate binding sites in
the enzyme [41].
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Figure 1.3. Representation of the active center of ACK. Associated with the nucleotidebinding region is the catalytic carboxyl that has ATP as its immediate phosphoryl donor.
Associated with the acetate (and acetyl-P) binding region is an unknown group (X) that
has acetyl-P as its immediate phosphoryl donor. The phosphoryl group is reversibly
transferable between X and the carboxyl group. All phosphoryl transfers among
substrates and the catalytic groups proceed with steric inversion on the phosphorus. It is
conjectured that the intermediate E-X-PO3 is at a higher energy level than E-COOPO3,
because only the latter is isolated when the enzyme is phosphorylated by ATP or acetylP. Taken from [41].
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More recent research on the M. thermophila ACK suggests that the enzyme
functions through a single displacement or direct, in-line phosphoryl transfer mechanism.
A number of phosphoryl transfer enzymes, both phosphatases and kinases, have been
mechanistically studied using aluminium fluoride, which mimics the planar phosphoryl
group in the transition state [44-46]. Pre-incubating the M. thermophila ACK with
magnesium chloride, ADP, aluminium chloride, and sodium fluoride inhibited the
activity of the enzyme by forming an abortive active site complex (Figure 1.4) [47].
Miles et al. [47] reported that the rate of observed inhibition was slow for enzyme-ligand
interactions, but could be attributed to the sluggish rate of aluminium fluoride complex
formation which had been previously observed [48]. In the absence of ADP and
magnesium chloride (Figure 1.3, inset) no detectable loss of activity was observed [48].
This evidence indicated that the presence of magnesium chloride, ADP, acetate, and
aluminium fluoride are required for maximum inhibition of the M. thermophila ACK
(Table 1.4) [47].
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Figure 1.4. Inhibition of M. thermophila ACK by MgCl2, ADP, AlCl3, NaF, and acetate.
ACK (0.4 µM dimer) was pre-incubated for the indicated times in a mixture containing
MgCl2 (10 mM), ADP (10 mM), AlCl3 (0.1 mM), NaF (0.5 mM), and potassium acetate
(25 mM) in 100 mM BisTris buffer (pH 5.5). The enzyme activity was then assayed and
plotted relative to 100% activity (600 µmol of acetyl phosphate/min/mg of protein)
obtained from a control mixture in which AlCl3 and NaF were omitted. Inset, the time
course of the activity assay after pre-incubation for 30 min with: complete inhibitory
mixture (y), minus NaF and AlCl3 (■), minus MgCl2, ADP and acetate (♦), minus all
components except buffer (▲). Taken from [47].
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Table 1.4. Inhibition of the ACK from E. coli or M. thermophila. Taken from [47].

a

The enzyme (0.4 µM dimer) was pre-incubated for 30 min with MgCl2 (10 mM), ADP

(10 mM), AlCl3 (0.1 mM), NaF (0.5 mM), and acetate (25 mM) unless otherwise noted
before the activity was assayed.
b

100% (approximately 600 µmol of acetyl phosphate/min/mg of protein) is the activity

of the enzyme pre-incubated for 30 min with the indicated concentrations of MgCl2,
ADP, and acetate.
c

100% (approximately 630 µmol of acetyl phosphate/min/mg of protein) is the activity

of the enzyme pre-incubated for 30 min with the indicated concentrations of MgCl2,
ADP, and acetate.
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Gorrell et al. [22] solved structures of the M. thermophila ACK with the ADPaluminium fluoride-acetate transition state analog which allowed additional examination
of the R91 and R241, residues previously implicated in acetate binding and catalysis [21].
A structure with the non-hydrolyzable ATP analog ATPγS supported the evidence
presented by Miles et al. [47] that ATPγS is bound equivalently to the binding of ATP in
the active site displacing the β-phosphate and theoretically the γ-phosphate of ATP [22].
Kinetic parameters in both the acetate-forming and acetyl phosphate-forming directions
for all of the R91 and R241 variants indicated these residues were essential for catalysis
in the acetyl phosphate-forming direction (Table 1.5). Significant decreases in kcat values
for R91 and R241variants in the acetate-forming direction were also observed. (Table
1.6) [22].
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Table 1.5. Kinetic parameters of wild-type and variant ACKs in the forward (ADP/AcP
synthesis) direction. Taken from
[22].
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Table 1.6. Kinetic parameters of wild-type and variant ACKs in the reverse (ATP/acetate
synthesis) direction. Taken from
[22].
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R91 and R241 were previously postulated to interact with the phosphoryl group of
acetyl phosphate and the carbonyl oxygen of acetate [21]; however, Gorrell et al. [22]
noted that the negligible changes in the Km values for acetyl phosphate for the R91 and
R241variants did not provide sufficient evidence to implicate either residue in binding the
phosphoryl group of acetyl phosphate. Conversely, the significant changes in the Km
values for acetate for the R91 and R241 variants supported previous evidence for these
two residues in acetate binding [21]. The increases in the Km values for acetate for the
R91K and R241K variants were much less than for variants replaced with alanine and
leucine (Table 1.5), confirming a requirement for a positive charge at these positions
which would interact with the carboxyl group of acetate [22].
Gorrell et al. [22] proposed a catalytic mechanism (Figure 1.5) in which
additional residues that are important in substrate binding and catalysis were identified. A
role for H180 in stabilizing the transition state was previously proposed based on variant
studies [21, 26]. In the analysis of the aluminium fluoride crystal structures, Gorrell et al.
[22] discussed the close proximity of H180 along with the R241 residue to the aluminium
fluoride in the structure. They concluded that this proximity is consistent with
stabilization of the transition state and that H180 also interacted with γ-phosphate of
ATP. Furthermore, evidence was provided by the new structure that supported enzyme
catalysis involving E384, and D148 which have been implicated in magnesium binding
[28].
Gorrell et al. [22] described the mechanism as a SN2 nucleophilic attack by the
carboxyl group of acetate upon the γ-phosphate of ATP through a trigonal bipyramidal
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transition state (Figure 1.4B), with stabilization of the equatorial oxygen atoms through
an interaction with H180 and R241. In addition, H180 is proposed to interact with the
phosphoryl group of acetyl phosphate similar to its interaction with acetate, which may
implicate this residue in orientating acetyl phosphate for attack by ADP [22].
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Figure 1.5. Postulated mechanism of ACK from M. thermophila for the forward (AcPproducing) reaction direction. A, ATP and acetate substrate interactions with ACK; B,
interactions for the proposed direct in-line mechanism transition state; C, interactions of
the products ADP and AcP with ACK. The arrows indicate direction of electron
movement. Taken from [22].
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III. ACETATE KINASE IN THE EUKARYA
Although previously thought to be present in bacteria and one genus of archaea,
ACK is now known to be present in all three domains of life [49]. Very little is currently
known about the eukaryotic ACKs except knowledge gained from bioinformatic and
phylogenetic analyses. Through BLAST searches, ACKs have been identified in three of
the four fungal phyla: Ascomycota, Bastidiomycota, and Chytridiomycota [49]. In
addition, ACK sequences have been identified in oomycetes (Phytophthora spp.),
unicellular green alga (Chlamydomonas reinhardtii), and a protozoan parasite
(Entamoeba histolytica) (Figure 1.6) [49]. Fungi lack PTA, and ACK has been proposed
to instead partner with xylulose 5-phosphate/fructose 6-phosphate phosphoketolase
(XFP) allowing sugar phosphates to be utilized to generate ATP (Figure 1.7a) [49].
Interestingly, eukaryotic ACKs from Phytophthora and Chlamydomonas utilize
phosphotransacetylase (PTA) as a partner (Figure 1.7b) [49]. Furthermore, it has been
hypothesized that the presence of two ACK ORFs and two PTA ORFs in C. reinhardtii
may suggest the two ACK-PTA pathways operating in opposing directions which may be
influenced by varying growth conditions [49]. Because C. reinhardtii can utilize acetate
as a carbon growth source, the ACK-PTA pathway could allow for the generation of
acetyl-CoA and eventually triose via the glyoxylate cycle [50]. This would be a second
pathway for acetate activation as AMP-ACS is present in C. reinhardtii. Inversely, a
suggested PTA-ACK pathway functioning in the direction of acetate formation would
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allow for the generation of ATP via acetate fermentation [51].
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Figure 1.6. Phylogeny of ACK. The deduced amino acid sequences of acetate kinases
(AKs) and the closely related propionate kinases (PKs) and butyrate kinases (BKs) from
the draft and completed genome sequences available at NCBI (www.ncbi.nlm.nih.gov),
the Broad Institute (http://www.broad.mit.edu/annotation/fgi/) and the U.S. Department
of Energy Joint Genome Institute (http://genome.jgi-psf.org/euk_cur1.html). Sequences
were aligned with ClustalX [21] and phylogenetic analysis was performed with MEGA
[22] using the neighbor-joining algorithm. The data were analyzed using the complete
deletion option and the tree was constructed using a gamma distance a=2. The reliability
of each tree was examined with 1000 bootstrap replicates with values >80% shown. For
brevity, only a representative set of bacterial sequences were used for the ACK tree
presented here and the clade containing the BKs is not shown. AK sequences from
bacteria are shown in black, archaea in blue and eukaryotes in red. Taken from [49].
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A.

B.

Figure 1.7. Proposed pathways for ACK in Eukaryotic microbes. (a) In Chlamydomonas
reinhardtii and Phytophthora species, the ACK–PTA pathway (blue) could be used in the
assimilation of acetate in the presence of high extracellular acetate concentrations or
could operate in the reverse direction to generate ATP from excess acetyl-CoA. The
presence of two ACK ORFs and two PTA ORFs in C. reinhardtii raises the possibility
that two ACK–PTA pathways operate in opposite directions under different growth
conditions. (b) In fungi, the ACK–XFP pathway (red) could function during growth in
the breakdown of sugars to produce acetate and ATP. The acetate produced could then be
converted to acetyl-CoA through the action of ACS. Taken and modified from [49]. A
PTA (grey) is absent in fungi.
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IV. THE PARASITE ENTAMOEBA HISTOLYTICA
Entamoeba histolytica is a protozoan parasite of the phylum Amoebozoa. The
parasite was first noted in 1875, but not fully described until 1903 as the causative agent
of amoebiasis. An intestinal disease of humans, which is primarily present in Mexico,
India, sub-Saharan Africa, and developing countries throughout the world, amoebiasis is
a waterborne illness, causing dehydration, diarrhea, and sometimes extreme dysentery.
Due to the limited resources of modern medicine in the remote locations where E.
histolytica dominates, the protozoan has become a considerable source of morbidity and
mortality, estimated to infect more than 50 million people worldwide [52].
The life cycle of the parasite begins with ingestion of an infectious cyst. The cyst
form is non-dividing, and consists of a quadrinucleated structure consisting of a chitinous
cell wall. This chitin-containing cell wall protects the cyst from the acidic environment of
the stomach [53, 54]. Once the cyst enters the small intestine, excystation occurs,
producing the active trophozoite. The trophozoite binds to the mucosal walls of the host’s
colon and begins colonization. Penetration of the mucosal barrier results in disease in the
host either by direct destruction of the intestinal epithelium, or by more hostile invasion
of the host. Motile trophozoites of E. histolytica are capable of disseminating into other
body tissues where abscesses can form if left untreated (Figure 1.8).
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Figure 1.8. Life cycle of E. histolytica. The mature cyst is ingested by the human host.
Excystation of the cyst occurs in the small intestine where the active trophozoite is
produced. The trophozoite can then replicate by binary fission to form additional
trophozoites, or can undergo encystation to produce a number of cysts. Cysts are passed
into the host’s feces where water-borne transmission allows for continuation of the
parasite’s life cycle. Taken from [55].
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E. histolytica has a functionally tetraploid genome; however, it has been noted that the
ploidy of individuals varies from cell to cell [56] and in an assortment of growth
conditions [57]. The genome consists of both linear chromosomes and circular, plasmidlike molecules containing a low G+C content of 22.4%; with nearly all genes lacking
introns [58, 59]. Because the genome has an unknown ploidy and complex variations in
both cell cycles and cell structure nucleation, a consistent complete assembly of the
genome has not been accomplished.
Pathogenesis in E. histolytica is primarily dependent on adherence of the
organism to the intestinal mucosa [60]. This process is accomplished by the presence of
galactose/N-acetyl galactosamine binding receptors on the surface of the parasite and has
been implicated in both virulence and cellular differentiation [61]. The protein has also
been shown to play an important role in a number of other processes, including vesicle
trafficking [62] and participation in dynamic cytoskeleton reorganization [63].
The production of a cytotoxic amoebapore protein has been shown to be essential
in host invasion and nutrient sequestering in the host’s intestinal environment. Strains of
E. histolytica lacking amoebapore-A are avirulent, implicating this protein as a critical
factor in pathogenesis [64, 65]. The protein is responsible for the liberation of host cell
components by the creation of these ion channels resulting in a loss of membrane
integrality and failure, and ultimately leading to a significant loss of intestinal fluid; a
hallmark of amoebic dysentery [66].
The parasite also produces a number of cystine proteases which are thought to
degrade proteins and enzymes secreted by the host immune system [67], selectively
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damage enteric cells [68], and participate in processing of intracellular host proteins [69]
liberated by amoebapore.
Treatment for E. histolytica infection typically involves the administration of two
drugs. Metronidazole (Flagyl), a nitromidazole which interacts with protozoal ferredoxin
of PFOR to produce toxic byproducts is used to treat invasive trophozoites. In addition,
paromomycin (Humatin) an aminoglycoside, is used as a luminal amoebicide [70].
Problems arising from observed in vitro amoebic resistance to metronidazole and in vivo
cytotoxic and nephrotoxic effects from paromomycin indicate a need for the
identification of novel drug targets in this parasite [52].
ATP synthesis in E. histolytica is primarily limited to substrate-level
phosphorylation. The parasite lacks a mitochondrion, but does have a complete pentose
phosphate pathway capable of metabolising various carbohydrate substrates (e.g.
galactose, fructose, and other pentoses) [71]. Pathways for ATP synthesis via amino acid
degradation have also been identified in the genome sequence, but glycolysis remains a
staple pathway for ATP synthesis in the parasite [59, 72]. An extended glycolytic
pathway is present in which pyruvate is converted to acetyl-CoA by PFOR (Figure 1.9).
Acetyl-CoA is then converted to acetate by an ADP-forming ACS to generate ATP [73].
Amino acid catabolism by Entamoeba can lead to the generation of pyruvate in
the absence of glucose. Pyruvate or other ketoacids can be formed by the metabolism of
alanine, aspartic acid, asparagine, cystine, glutamine, glutamic acid, methionine, serine,
threonine, and tryptophan [74, 75]. PFOR has been shown to have broad substrate
specificity with the ability to oxidatively decarboxylate 2-ketobutanoate, oxaloacetate,
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and 2-ketoglutarate. 2-ketobutanoate, a product of threonine and methionine catabolism,
is converted to propionyl-CoA, which can be utilized by ADP-ACS as a substrate for
ATP generation. Entamoeba has also been shown to grow at normal rates under restricted
glucose and in the presence of the small chain fatty acids acetate, propionate, and
butyrate [76].
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Figure 1.9. Proposed metabolic pathway(s) for acetate synthesis and utilization in E.
histolytica. An extended glycolytic pathway is present in E. histolytica in which pyruvate
is converted to acetyl-CoA by the PFOR. Acetyl-CoA can then be converted to acetate by
and ADP-ACS. HK, hexokinase; 3-PGK, 3-phosphoglycerate kinase; PPDK,
phosphoenolpyruvate dikinase; HYD, hydrogenase; PFOR, pyruvate ferrodoxin
oxidoreductase; ADP-ACS, ADP-forming acetyl-CoA synthetase.
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V. REMAINING QUESTIONS CONCERNING ACETATE KINASE
In 1975, Reeves and Guthrie first described a PPi-dependent ACK activity in E.
histolytica [77]. At the time of the publication, modern molecular biology and
biochemistry techniques for the cloning and recombinant production of enzymes were not
possible. Due to the incomplete purification as well as limited quantity and concentration
of the native enzyme, a complete profile of the biochemistry, kinetics, and mechanism of
the E. histolytica ACK was not accomplished.
Within this dissertation, I have shown that the annotated ACK gene in the E.
histolytica genome encodes for a PPi-dependent not ATP-dependent ACK. I have
completed both biochemical and kinetic characterization of the recombinant E. histolytica
PPi-dependent ACK. This work has resulted in identifying commonalities and differences
between the ATP-dependent ACK found in M. thermophila and this unique PPidependent ACK from E. histolytica. Modification of the ACK assay first developed by
Lipmann [78], has made possible the kinetic characterization of the enzyme in the
acetate-forming direction of the ACK reaction, the physiological reaction of the enzyme.
Furthermore, the kinetic characterization of a number of enzyme variants has resulted in a
better understanding of the essential amino acid residues that comprise the active site of
this ACK.
Characterization of this novel enzyme is significant in gaining better
understanding of eukaryotic amitochondrial metabolism. In addition, the new assay
described in this dissertation may serve as a basis for generating new methods for
examining some of the other metabolic enzymes found in E. histolytica.
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CHAPTER II
DIRECT DETECTION OF THE ACETATE-FORMING ACTIVITY OF THE
ENZYME ACETATE KINASE
Matthew L. Fowler, Cheryl J. Ingram-Smith, and Kerry S. Smith
ABSTRACT
A method for the determination of acetate kinase activity is described. This assay
utilizes a direct reaction for determining enzyme activity and kinetics of acetate kinase in
the acetate-forming direction with different phosphoryl acceptors. Furthermore, this
method can be utilized for assaying other acetyl phosphate or acetyl-CoA utilizing
enzymes.
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I. INTRODUCTION
Acetate kinase, a member of the acetate and sugar kinase-Hsp70-actin (ASKHA)
enzyme superfamily [1-5], is responsible for the reversible phosphorylation of acetate to
acetyl phosphate utilizing ATP as a substrate. Acetate kinases are ubiquitous in the
Bacteria, found in one genus of Archaea, and are also present in microbes of the Eukarya
[6]. The most well characterized acetate kinase is that from the methane-producing
archaeon Methanosarcina thermophila [7-14]. An acetate kinase which can only utilize
PPi but not ATP in the acetyl phosphate-forming direction has been isolated from
Entamoeba histolytica, the causative agent of amoebic dysentery, and has thus far only
been found in this genus [15, 16].
In the direction of acetyl phosphate formation, acetate kinase activity is typically
measured using the hydroxamate assay, first described by Lipmann [17-20], a coupled
assay in which conversion of ATP to ADP is coupled to oxidation of NADH to NAD+ by
the enzymes pyruvate kinase and lactate dehydrogenase [21, 22], or an assay measuring
release of inorganic phosphate after reaction of the acetyl phosphate product with
hydroxylamine [23]. Activity in the opposite, acetate-forming direction is measured by
coupling ATP formation from ADP to the reduction of NADP+ to NADPH by the
enzymes hexokinase and glucose 6-phosphate dehydrogenase [24].
Here we describe a method for the detection of acetate kinase activity in the
direction of acetate formation that does not require coupling enzymes, but is instead
based on direct determination of acetyl phosphate consumption. After the enzymatic
reaction, remaining acetyl phosphate is converted to a ferric hydroxamate complex that
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can be measured spectrophotometrically, as for the hydroxamate assay. Thus, unlike the
standard coupled assay for this direction that is dependent on the production of ATP from
ADP, this direct assay can be used for acetate kinases that produce ATP or PPi.
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II. MATERIALS AND METHODS
The overall scheme of this protocol is outlined in Figure 2.1.
1) Solution Preparation for Standard Curves and Assays
1.1) Prepare 100 mL of a 2 mol/L solution of hydroxylamine-HCl. Weigh out 13.9 g of
hydroxylamine hydrochloride (MW 69.49 g/mol) and dissolve in approximately 50 mL
distilled-deionized water (ddH2O). Adjust the pH to 7.0 using potassium hydroxide
pellets or a concentrated solution. Bring the final volume to 100 mL. The solution can be
stored at room temperature for up to 30 days or at 4°C for up to 90 days.

1.2) Prepare 100 mL of a ferric chloride/ hydrochloric acid solution. Weigh out 13.5 g
ferric chloride (MW 270.32 g/mol) and dissolve in approximately 50 mL ddH2O. Add
41.3 mL concentrated hydrochloric acid (12.1 mol/L) and bring to a final volume of 100
mL. The final concentration of ferric chloride will be 0.5 mol/L and the final
concentration of hydrochloric acid will be 5 mol/L. The solution is stored at room
temperature.

1.3) Prepare 100 mL of a 1.84 mol/L solution of trichoroacetic acid. Weigh out 30.0 g of
trichloroacetic acid (MW 163.39 g/mol), dissolve in ddH2O and bring the final volume to
100 mL. The solution is stored at room temperature.
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Protocol Scheme
1. Generate an acetyl phosphate standard curve
2. Dilute enzyme to desired concentration
3. Prepare the reaction mixture and aliquot 300 µl to microcentrifuge tubes
4. Preincubate reactions at 37°C for 1 minute
5. Start reactions by adding enzyme at specific time intervals
6. Add hydroxylamine at the same intervals to stop the reactions and incubate
at 60°C for 5 minutes
7. Add ferric chloride/trichloroacetic acid solution for color development
8. Centrifuge tubes at 18,000 x g for 1 minute
9. Measure absorbance at 540 nm
10. Determine amount of acetyl phosphate consumed by comparison to the
standard curve
Figure 2.1. Protocol Scheme.
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1.4) Prepare 5 mL of a 0.1 mol/L acetyl phosphate solution. Weigh out 0.092 g acetyl
phosphate (MW 184.06 g/mol), dissolve in ddH2O and bring the final volume to 5 mL.
Aliquot the solution to microcentrifuge tubes (0.25 mL per tube) and freeze at -20°C until
use. Thawed solution should be placed on ice and can be used for approximately 1 hour.
Acetyl phosphate solution that has been thawed should not be refrozen and re-used.

1.5) Prepare 5 mL of a 0.1 mol/L solution of ADP. Weigh out 0.24 g of ADP (MW 472.5
g/mol), dissolve in ddH2O, and bring the final volume to 5 mL. Aliquot the solution in
microcentrifuge tubes (0.5 mL per tube) and freeze at -20° C until use. Keep thawed
solution on ice until use.

1.6) Prepare 50 mL of a 1 mol/L solution of Tris. Weigh out 6.06 g Tris (MW 121.14
g/mol), and dissolve in 40 mL ddH2O. Adjust the pH of the solution to 7.0 using
hydrochloric acid and bring final volume to 50 mL. Store solution at room temperature.

1.7) Prepare 10 mL of a 1 mol/L magnesium chloride solution. Weigh out 2.03 g
magnesium chloride (MW 203.31 g/mol), dissolve in ddH2O, and bring final volume to
10 mL. Store the solution at room temperature.

1.8) Prepare 25 mL development solution by mixing equal volumes of the ferric
chloride/hydrochloric acid solution and the trichloroacetic acid solution. Development
solution should be prepared fresh each day and stored at room temperature.
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2) Preparation of an Acetyl Phosphate Standard Curve
2.1) An acetyl phosphate standard curve is generated using known amounts of acetyl
phosphate. A standard curve of six to eight points is suitable. The standards should range
from 0.03 µmoles to 0.9 µmoles per 300 µL, which correlates to final concentrations of
0.1 to 3 mmol/L. Dilute the acetyl phosphate stock solution to the appropriate
concentrations in 100 mM Tris solution in a final volume of 300 µL. A control sample
without acetyl phosphate should also be prepared.

2.2) Incubate each standard and the control at 37°C in a heat block for 1 minute.

2.3) Add 50 µL of the hydroxylamine hydrochloride solution to each standard and the
control and mix by shaking three times. Place the standard into a 60°C heat block and
incubate for five minutes.

2.4) Add 100 µL of development solution to the standards and the control, mix by
shaking three times, and allow color to develop for at least one minute at room
temperature.

2.5) Centrifuge all standards and the control in a microcentrifuge at 18,000 x g for 1
minute.
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2.6) Measure the samples spectrophotometrically at 540 nm using 1mL plastic cuvettes,
using the control as the blank for spectrophotometry.

2.7) Generate a standard curve using appropriate data analysis and graphing software
(e.g. Kaleidagraph, Synergy Software). R2 values of 0.99 or greater are desirable. The
data is plotted as absorbance at 540 nm versus µmoles of acetyl phosphate present.

3) Assay for Acetate Kinase Activity
3.1) Using the solutions described, prepare a reaction mix containing a final
concentration of 0.1 mol/L Tris buffer, 10 mmol/L magnesium chloride, 5 mmol/L ADP,
and 2 mmol/L acetyl phosphate. A 10 mL reaction mixture will require 8.2 mL ddH2O,
1.0 mL Tris solution, 0.1 mL magnesium chloride solution, 0.5 mL ADP solution, and
0.2 mL acetyl phosphate solution. . Distribute the reaction mix in 300 µl aliquots to
microcentrifuge tubes. For determination of kinetic parameters and optimization of
substrate concentrations, one substrate can be varied and the other held at a constant
concentration in the reactions.

3.2) Pre-incubate the reactions for 1 minute at 37°C in a heat block.

3.3) Add a desired amount of enzyme to the reaction and immediately return the tube to
the 37°C heat block. Also include a control reaction to which no enzyme is added. If
several reactions are performed, add enzyme to the tubes at specific time intervals. Be

74

sure to keep track of time. (NOTE: The amount of enzyme to be used will need to be
optimized to ensure that all of the acetyl phosphate or ADP substrate will not be depleted
- see Discussion section)

3.4) After 5 minutes, add 50 µL of the hydroxylamine hydrochloride solution to each
reaction and the control, mix, and place the tubes in a 60°C heat block. If several
reactions are being performed, this should be done at the same time interval as the
enzyme was added.

3.5) Incubate the reactions and the control for 5 minutes at 60°C.

3.6) Add 100 µL of the development solution to each reaction and the control, mix, and
place in a tube rack on the lab bench. Allow color to develop for at least 1 minute.

3.7) Centrifuge all tubes in a microcentrifuge at 18,000 x g for 1 minute.

3.8) Measure samples spectrophotometrically at 540 nm using 1mL plastic cuvettes and
determine the amount of acetyl phosphate present by comparison to the acetyl phosphate
standard curve.

3.9) The amount of acetyl phosphate substrate depleted can be determined by subtracting
the amount of acetyl phosphate remaining after the enzymatic reaction from the amount
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of acetyl phosphate present in the control lacking enzyme. Perform data analysis using
appropriate data and graphing software (e.g. Kaleidagraph, Synergy Software). R2 values
of greater than 0.97 are desirable.
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III. RESULTS
The purpose of this assay is to measure acetate kinase activity in the direction of
acetate formation. This is done by measuring consumption of the acetyl phosphate
substrate, as there is no easy, direct measurement for acetate production. Acetyl
phosphate remaining after a given time during the enzymatic reaction is converted to
acetyl hydroxamate and subsequently to ferric hydroxamate complex, which has a
reddish color (Figure 2.2) that can be measured at 540 nm. The standard curve plotting
absorbance versus µmoles acetyl phosphate present in the standards is used to determine
the amount of acetyl phosphate remaining in each reaction. The standard curve should be
linear through the zero point. A representative standard curve shown in Figure 2.3 has a
slope of 1.2332 absorbance units per µmole acetyl phosphate present and an R2 value of
0.99, indicating the data fits the linear equation well. The equation for the linear fit to the
standard curve data is used for calculating the quantity of acetyl phosphate remaining in
the reaction. The µmoles of acetyl phosphate consumed is determined as the difference
between the µmoles of acetyl phosphate present in the control reaction lacking enzyme
and the µmoles of acetyl phosphate remaining after the enzymatic reaction.
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Figure 2.2. Acetyl phosphate standards. Increasing concentrations of acetyl phosphate
were reacted with hydroxylamine and color was developed with the ferric
chloride/trichloroacetic acid solution as described. The control lacking acetyl phosphate
is bright yellow, and reactions containing increasing amounts of acetyl phosphate are
successively darker in color. This color change is measured at 540 nm.
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For the experiment shown in Figure 2.4, the concentration of ADP was held
constant at 5 mM and the concentration of acetyl phosphate in the reaction was varied to
determine the Km for acetyl phosphate. As expected, this experiment demonstrates that
the enzyme follows standard Michaelis-Menten-like kinetics for each substrate and
produced a hyperbolic saturation curve when plotting activity versus acetyl phosphate
concentration. The apparent Km value for acetyl phosphate was 0.27 ± 0.01 mM, which
compares favorably to the published Km value of 0.47 ± 0.01 mM using the coupled assay
[13].
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Figure 2.3. Sample acetyl phosphate standard curve. Varying concentrations of acetyl
phosphate were reacted with hydroxylamine and ferric chloride/trichloroacetic acid and
color development was measured at 540 nm. The absorbance at 540 nm versus
acetyl phosphate was plotted and a linear fit to the data was applied.
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Purified, recombinant M. thermophila acetate kinase was assayed using the
described protocol. For the experiment shown in Figure 2.4, the concentration of ADP
was held constant at 5 mmol/L and the concentration of acetyl phosphate in the reaction
was varied to determine the Km for acetyl phosphate. As expected, this experiment
demonstrates that the enzyme follows standard Michaelis-Menten-like kinetics for each
substrate and produced a hyperbolic saturation curve when plotting activity versus acetyl
phosphate concentration. The apparent Km value for acetyl phosphate was 0.27 ± 0.01
mmol/L, which compares favorably to the published Km value of 0.47 ± 0.01 mmol/L
using the coupled assay [13].
The direct assay can also be used to measure activity of acetate kinases that utilize
substrates other than ATP, which is not possible using the standard coupled assay.
Purified recombinant E. histolytica acetate kinase [16], which produces PPi rather than
ATP in the acetate-forming direction, was subjected to this assay using sodium phosphate
in place of ADP. The concentration of sodium phosphate in the reaction was held
constant at 0.2 mol/L and the acetyl phosphate concentration was varied. As for the M.
thermophila acetate kinase, the E. histolytica acetate kinase followed Michaelis-Mentenlike kinetics for acetyl phosphate and a hyperbolic saturation curve was observed (Figure
2.5). The apparent Km value for acetyl phosphate was 0.50 ± 0.006 mmol/L. Reeves and
Guthrie [15] determined a Km value of 0.06 mmol/L for acetyl phosphate for the native
enzyme; however, their enzyme was only partially purified and their assay involved four
coupling enzymes which were also only partially purified. Thus, it is difficult to directly
compare these values.
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Figure 2.4. Utilization of acetyl phosphate by the ATP-producing M. thermophila ACK.
Enzymatic activity was determined in the direction of acetate formation in the presence
of 5 mM ADP with varying concentrations of acetyl phosphate. Assays were performed
in triplicate with error bars shown.
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Figure 2.5. Utilization of acetyl phosphate by the PPi-producing E. histolytica ACK.
Enzymatic activity in the direction of acetate formation was determined in the presence
of 200 mM sodium phosphate with varying concentrations of acetyl phosphate. Assays
were performed in triplicate with error bars shown.
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IV. DISCUSSION
The detection of acetyl phosphate in this assay is dependent upon a sufficient
concentration of hydroxylamine hydrochloride and the concentration and acidity of the
ferric chloride solution. Alteration of the assay volume will require reconsideration of
both of these components. The enzymatic reactions described here were performed at
37°C with the hydroxylamine termination performed at 60°C for 5 minutes. This higher
temperature is critical to allow for rapid conversion of the remaining acetyl phosphate to
acetyl hydroxamate. The timing of the color development step and measurement of
absorbance is less critical, and can be performed in as little as 5 minutes and up to 15
minutes following the addition of the hydroxylamine solution. The samples should be
centrifuged before reading the absorbance, as the acidity of the sample may lead to
precipitation of the enzyme and can produce a falsely high reading due to turbidity rather
than actual color change. Breakdown of the developed reactions will begin to occur after
10-15 minutes.
The primary complications of this assay for examining enzyme kinetics are
determination of the amount of enzyme to use and the length of time to run the first step
of the reaction. These must be determined empirically for each enzyme such that the level
of activity is not so high that all of the acetyl phosphate substrate is consumed. Careful
attention should be given to the percent acetyl phosphate consumption for each reaction
point in a kinetic curve. Generally, lower concentrations of the varied component on a
kinetic curve should result in acetyl phosphate consumption up to 90 percent or slightly
above, while consumption of acetyl phosphate at saturating substrate concentrations
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should approach 10 percent or slightly less. Once the enzyme concentration is optimized,
the substrate range for determination of kinetic constants can then be determined.
Previous methods for measuring acetate kinase activity in the acetate-forming direction
involved the use of coupled assays. These methods are problematic with respect to
kinetic calculations due to dependence on the activity of the coupling enzyme(s), whose
assay conditions (pH, ionic strength, temperature, etc.) may be incompatible with the
optimal assay conditions for the enzyme of interest. In addition, use of a direct assay for
studies with inhibitors may avoid issues that could arise from inhibition of the coupling
enzymes. Overall, this assay should be useful not only for acetate kinase, but for any
enzyme that utilizes acetyl phosphate or other activated short chain acyl substrates such
as acetyl- or propionyl-CoA, propionyl phosphate, and acetyl-AMP, all of which are
reactive with hydroxylamine. In these cases, the standard curve would be generated with
the appropriate acyl substrate instead of with acetyl phosphate.
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CHAPTER III
BIOCHEMICAL AND STRUCTURAL CHARACTERIZATION OF A
NOVEL PPI-DEPENDENT ACETATE KINASE FROM THE PARASITE
ENTAMOEBA HISTOLYTICA

Matthew L. Fowler, Tarjani M. Thaker, Mikio Tanabe,
Cheryl Ingram-Smith, Tina M. Iverson, and Kerry S. Smith

ABSTRACT
Acetate kinase (ACK) catalyzes the reversible magnesium dependent synthesis of
acetyl phosphate by transfer of the γ-phosphate of ATP to acetate. Here we report the
biochemical, kinetic, and structural characterization of the E. histolytica ACK, the only
known member of the ASKHA structural superfamily that utilizes PPi as the sole
phosphoryl donor. The enzyme is capable of utilizing acyl substrates as long as
hexanoate in the direction of acetyl phosphate synthesis. The kinetic parameters for
substrate affinity indicate that the enzyme prefers both acetate and propionate in the
acetyl phosphate-forming direction; however, the low kcat raises question whether this
direction of the reaction is physiological. Studies of the mechanism of this enzyme
indicates that the PPi-ACK follows a sequential mechanism, supporting a direct in-line
phosphoryl transfer mechanism previously reported in the most well characterized
Methanosarcina thermophila ATP-dependent ACK. We determined the crystal structure
of the E. histolytica ACK to 2.4Å resolution. The structure contains two monomers
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related by pseudo two-fold rotational symmetry to form a dimer. This overall shape is
similar to that observed in other members of the ASKHA superfamily. Comparison of the
structure of the E. histolytica ACK to that of M. thermophila ACK determined in the
presence of both ADP•AlF4- and acetate suggests the presence of one active site in each
monomer, with two active sites in each dimer. Docking models indicate that acetate binds
to a location structurally analogous to the acetate binding site in the M. thermophila
ACK, and the pyrophosphate binding to a location structurally analogous to the βphosphate and AlF4 of the ADP-AlF4 binding site in MtACK. Docking simulations could
not identify a reasonably binding site for either ATP or ADP within the E. histolytica
ACK structure. ATP binding is sterically unfeasible in the E. histolytica further
supporting the role of this enzyme as a PPi-dependent ACK.
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I. INTRODUCTION
Acetate kinase (ACK), a key enzyme in energy generation in prokaryotic
metabolism, catalyzes the reversible transfer of the γ-phosphoryl group of ATP to acetate
to form acetyl phosphate and ADP (equation 1).
CH3COO- + ATP ↔ CH3COPO42- + ADP

[1]

ACK is a member of the ASKHA phosphotransferase superfamily, which includes
acetate kinase, hexokinase and other sugar kinases, as well as the Hsp70 heat shock
cognate and actin [1-4]. In 2001, Buss et al. [5] published the first structure for an ACK,
that from the archaeon Methanosarcina thermophila, and suggested that ACK is the
urkinase for the ASKHA superfamily.
Several crystal structures have now been solved for the well characterized M.
thermophila ACK [5, 6] and the roles of a number of active site residues in substrate
binding and catalysis have been examined experimentally [7-12]. Kinetic and structural
studies support a direct in-line transfer of the phosphoryl group of ATP to acetate. The
positions of the ATP ligand and the proposed acetate binding pocket in the M.
thermophila ACK structure are consistent with direct in-line transfer of the phosphoryl
group [5, 6]. Furthermore, a MgADP-AlF3-acetate transition state analog [12] resulted in
an abortive complex and was found to be in a linear array in the active site [6]. Based on
analysis of site-altered enzyme variants [7, 11, 13] and structural studies, Gorrell et al. [6]
have postulated a mechanism detailing the roles of active site residues in catalysis. The
active site residues implicated in this mechanism are well conserved among the ACKs,
consistent with their key roles in catalysis.
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In 1975, Reeves and Guthrie [14] identified a PPi-dependent ACK activity in
Entamoeba histolytica, an amitochondriate protist that is the causative agent of amoebic
dysentery and is currently listed as the third leading cause of morbidity and mortality due
to parasitic disease in humans after malaria and schistosomiasis [15]. Here we report the
biochemical, kinetic, and structural characterization of the E. histolytica ACK, the only
known member of the ASKHA structural superfamily that utilizes PPi as the sole
phosphoryl donor.
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II. RESULTS
E. histolytica has a PPi-dependent ACK. In 1962, Bragg and Reeves [16]
reported an ATP-dependent ACK in the non-pathogenic E. histolytica strain Laredo (now
Entamoeba moshkovskii). However, this strain was grown in the presence of bacteria,
raising the possibility that this activity was of bacterial origin. Thirteen years later,
Reeves and Guthrie [14] identified a pyrophosphate (PPi)-dependent ACK in axenicallygrown E. histolytica. The deduced amino acid sequence of the ACK ORF (EHI_170010;
XM 650898.1) identified in the E. histolytica genome shares 34% identity and 53%
similarity to the well-characterized M. thermophila ACK (MtACK), which utilizes ATP
but not PPi as the phosphoryl donor and displays high activity in both directions of the
reaction [17]. To determine whether the encoded enzyme is indeed a PPi-dependent ACK
and to allow kinetic and biochemical characterization, recombinant E. histolytica ACK
(EhACK) was produced in E. coli and purified by nickel affinity chromatography to
electrophoretic homogeneity.
The purified recombinant enzyme utilized PPi as a phosphoryl donor in the acetyl
phosphate-forming direction of the reaction (Figure 3.1a) and displayed normal
hyperbolic saturation curves for both acetate and PPi. Unlike all other characterized
ACKs, EhACK shows only PPi-dependent activity in the direction of acetyl phosphate
formation. ATP does not serve as a phosphoryl donor (Figure 3.1a) nor do other NTPs
(CTP, GTP, TTP, UTP, and ITP; data not shown) or ADP. In the acetate-forming
direction of the reaction, the enzyme displayed a normal hyperbolic saturation curve with
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inorganic phosphate as the phosphoryl acceptor, and no activity was observed with ADP,
AMP, or PPi in the acetate-forming direction (Figure 3.1b).
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A.
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B.

Figure 3.1. Utilization of different phosphoryl donors and acceptors by EhACK. (A)
Enzymatic activity in the acetyl phosphate-forming direction of the reaction in the
presence of 1 M acetate with varying concentrations of each phosphoryl donor was
measured using the hydroxamate assay. (z) PPi, ({) ADP, and (U) ATP. (B) Enzymatic
activity in the direction of acetate formation in the presence of 2 mM acetyl phosphate
with varying concentrations of each phosphoryl acceptor was determined using the
modified reverse hydroxamate assay. (z) Pi, ({) PPi, (U) ADP, and ( ) AMP.
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EhACK prefers the acetate/PPi-forming direction of the reaction
In the acetate/ATP-forming direction of the reaction, the apparent Km value for
acetyl phosphate was determined to be 0.5 ± 0.1 mM and the kcat was 1939 ± 14 sec-1
(Table 3.1). In the acetyl phosphate/Pi-forming direction of the reaction, the Km value for
acetate was 106.8 ± 1 mM and the kcat value was 1.76 ± 0.01 sec-1 (Table 3.1). The
significantly higher Km value for acetyl phosphate versus acetate combined with the over
1000-fold higher kcat observed with acetyl phosphate suggest that the physiological
direction of the reaction is acetate/PPi formation.
In the acetyl phosphate/Pi-forming direction of the reaction, EhACK was found to
have a broad acyl substrate range, utilizing substrates as long as octanoate (C8). Although
the apparent Km value decreased with increasing acyl chain length, the turnover rate kcat
also decreased (Table 3.1). The catalytic efficiency kcat/Km with acetate was similar to that
observed with propionate (Table 3.1), and both values were significantly higher than
observed with any other acyl substrate. The apparent Km values for PPi remained
relatively unchanged with different acyl substrates with the exception of hexanoate
(Table 3.1). Activities with heptanoate and octanoate were too low for determination of
kinetic parameters, and the enzyme was not able to use the branched-chain acyl substrates
2-methylpropionate, 2-methylbutyrate, 3-methylbutyrate, 2-methylvalerate, 3methylvalerate, or 4-methylvalerate. Other acyl phosphates are not commercially
available and therefore acetyl phosphate was the only substrate tested in the acetate/PPiforming direction. The enzyme utilizes the cofactors Mg2+ (Km=2.1 ± 0.2 mM) and Co2+
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(Km=5.5 ± 0.4 mM), but no activity was observed with Ca2+, Cu2+, Ni2+ or Zn2+. Use of
Mn2+ resulted in less than 10% activity as compared to Mg2+.
To determine whether EhACK follows a sequential mechanism as shown by
Miles et al. [12] for MtACK or a ping pong mechanism consistent with a phosphoenzyme
intermediate as proposed by Anthony and Spector [18-20], we measured activity in the
acetate/PPi-forming direction in an array of reactions in which the acetyl phosphate and Pi
concentrations were varied. The double reciprocal plots of the activities versus substrate
concentrations resulted in intersecting lines (Figures 2A and B), consistent with a ternary
(sequential) mechanism and supporting a direct transfer of the phosphoryl group between
Pi and acetyl phosphate, similar to the in-line ternary mechanism for MtACK [12].
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Table 3.1. Kinetic parameters for EhACK.
kcat/Km

Phosphoryl

(mM-1 sec-1)

substrate

1939 ± 14

3846 ± 69

Pi

48.9 ± 0.8

106.8 ± 1.0

1.76 ± 0.01

0.016 ± 0.001

PPi

3.6 ± 0.1

propionate

79.8 ± 1.9

1.16 ± 0.01

0.015 ± 0.001

PPi

4.8 ± 0.3

butyrate

75.6 ± 1.5

0.33 ± 0.01

0.0043 ± 0.0001

PPi

3.2 ± 0.1

valerate

56.7 ± 0.7

0.19 ± 0.01

0.0034 ± 0.0001

PPi

6.3 ± 0.1

hexanoate

20.5 ± 0.5

0.051 ± 0.001

0.0025 ± 0.0001

PPi

16.3 ± 0.4

Km (mM)

kcat (s-1)

0.5 ± 0.1

acetate

Substrate
Acetyl phosphate
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B.

Figure 3.2. Double reciprocal plot of acetate-forming activity of EhACK. (a) The
reciprocal of the sodium phosphate concentration (40 mM, 50 mM, 60 mM, and 70 mM)
versus the reciprocal specific activity at acetyl phosphate concentrations of (z) 0.5 mM,
({) 0.7 mM, () 1.0 mM, and ( ) 1.5 mM. (b) The reciprocal of the acetyl phosphate
concentration of 0.5 mM, 0.7 mM, 1.0 mM, and 1.5 mM versus the reciprocal specific
activity at sodium phosphate concentrations of (z) 40 mM, ({) 50 mM, () 60 mM,
and ( ) 70 mM.
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Structure of E. histolytica ACK
We determined the crystal structure of EhACK to 2.4Å resolution. The structure
contains two monomers related by pseudo two-fold rotational symmetry to form a dimer.
This overall shape is similar to that observed in other members of the ASKHA
superfamily, which have previously been described as resembling the appearance of a
bird. In order to form this bird-like structure, the N- and C-termini of each monomer fold
into separate domains, with the C-terminal domain forming the “body” of the bird and
mediating dimerization, and the N-terminal domain forming the “wing” of the bird
(Figures 3.3A and 3.3B). Like other ASKHA family proteins, the C-terminal domain of
each EhACK monomer adopts the ribonuclease H-like motif, which is comprised of a
mixed β-sheet flanked by α-helical insertions (α/β/α fold) (Supplemental Figure 3.1) [1].
This ribonuclease H-like motif has greater sequence and structural similarity to the M.
thermophila ACK (for example, 36% identity, and a RMS deviation of 1.4 Å for 240 Cα
atoms) than does the wing domain (for example 31% identity, and a RMS deviation of
1.4 Å for 101 Cα atoms). The lower sequence and structural identity is especially in the
first 70 amino acids of the wing domain, which have only 21% sequence identity between
EhACK and MtACK.
Active site architecture
Co-crystallization of EhACK with acetate or pyrophosphate did not result in the
appearance of new electron density. However, a comparison of the structure of EhACK to
that of MtACK (PDB entry 1TUY) [6] determined in the presence of both ADP•AlF4- and
acetate suggests the presence of one active site in each monomer, with two active sites in
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each dimer. These active sites are positioned on opposite faces of the dimer at interfaces
between the wing and body domains, and are separated by 35 Å (Figures 3.3 and 3.4).
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A.
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B.

Figure 3.3. Overall architecture of EhACK. The E. histolytica ACK dimer is shown as a
ribbon diagram with the N-terminus of the protein (residues 1-142) colored in green, and
the C-terminus (residues 143-392) colored in silver-blue. The active site and location of
the predicted binding sites for products are highlighted with a dashed oval indicating the
likely binding sites for pyrophosphate and the dashed triangle indicating the likely
binding location for acetate. (A) The protein is shown in the orientation that most
resembles a bird, with the N-termini of each monomer forming the wings, and the Ctermini forming the body and mediating dimerization. The Figure 3.is aligned along the
pseudo two-fold of the body, which is represented with a silver-blue line. The wing
domains are related by a shifted pseudo two-fold axis, which is shown as a green line. (B)
A view of the E. histolytica ACK dimer rotated by 90°.
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Figure 3.4. Comparison of active site structure between MtACK and EhACK. (A)
Surface of MtACK showing cleft with docked ligands. (B) Surface of EhACK in same
orientation. (C) Stereo overlay of MtACK and EhACK showing side chains and docked
products.
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Docking of acetate and pyrophosphate, the putative products of the physiological
reaction catalyzed by EhACK, resulted in reasonable poses for each (Figure 3.4). In this
docking model, the acetate binds to a location structurally analogous to the acetate
binding site in MtACK, and the pyrophosphate binding to a location structurally
analogous to the β-phosphate and AlF4 of the ADP-AlF4 binding site in MtACK (Figure
3.4A and 4B). With the exception of the Pro Æ Thr substitution at position 223, residues
immediately surrounding both the acetate and the phosphate binding pockets are
completely conserved between EhACK and MtACK (Figure 3.4 C). In stark contrast,
conservative substitutions (GlyÆ Gln at position 323 and Ile Æ Met at position 324)
occlude the binding cleft for the adenosine ring of ATP in the EhACK enzyme (Figure
3.4A and B), rendering the binding of ATP or ADP sterically unfeasible. Not
surprisingly, docking simulations could not identify a reasonably scored pose for either
ATP or ADP within the EhACK structure (data not shown).

111

IV. DISCUSSION
Whereas ACKs in bacteria and archaea have been extensively studied,
significantly less is known about the biochemistry of eukaryotic ACKs. Here we report
detailed biochemical and kinetic characterization of the E. histolytica ACK, the only
known member of the ASHKA superfamily that utilizes PPi as sole phosphoryl donor.
Most of what is known about substrate binding and catalysis comes from studies on the
ACK from M. thermophila. Intriguing similarities and differences between the putative
active site of EhACK and the demonstrated active site of MtACK suggest how active site
architecture tunes specificity for Pi/PPi versus ADP/ATP.
An immediately notable difference is that MtACK contains a binding pocket for
the adenosine ring of the substrate ATP that is occluded by side chains in EhACK (Figure
3.4B) despite these two enzymes containing reasonable sequence identity in the active
site. Two prominent alterations account for the occlusion of the site: Gly to Gln and Ile to
Met at positions 323-324 of EhACK (positions 331-332 in MtACK) (Figure 3.4A). As a
result, ATP binding is sterically unfeasible in the E. histolytica enzyme (Figure 3.4A).
In addition, EhACK contains several unusual substitutions within the acetatebinding region of the active site, including the substitution of a Thr at position 223 in
EhACK for a conserved Pro at the equivalent position (residue 232) in MtACK and a
change in loop sequence and conformation between residues 110-125 of EhACK
(residues 116-131 of MtACK). These differences alter the potential ligands to the
acetate/acetyl phosphate substrate at two locations, and both decrease the hydrophobicity
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of the binding pocket and add putative hydrogen bonds for acetyl phosphate (Figure
3.4C).
The PPi-dependent ACK activity observed in cell homogenates supports previous
evidence suggesting that the enzyme is expressed in trophozoites. Microarray
experiments on E. histolytica have shown that ACK is expressed in genetically distinct
laboratory strains (HM-1:IMSS, Rahman, and 200:NIH) and in clinical isolates of both
cysts and trophozoites (strain MS75-3544 and 2592100) in a variety of different media
[21]. When taken together, these results indicate that ACK is expressed in both the
infective and non-infective stages.
The kinetic data presented here and elsewhere [14] suggests that ACK functions
primarily in the direction of acetate/PPi formation in Entamoeba. First, EhACK activity is
more than three orders of magnitude higher in the direction of acetate/PPi formation
versus acetyl phosphate/Pi formation; and secondly, the enzyme has a much stronger
affinity for acetyl phosphate than for acetate. Acetate/PPi formation catalyzed by ACK is
consistent with the physiology of this parasite. Unlike some eukaryotes, E. histolytica
lacks compartmentalized, ATP-generating mitochondria and hydrogenosomes and is
therefore limited to anaerobic metabolism [22]. Glycolysis deviates from that of most
other microbes in that PPi is used as an alternative to ATP as the phosphoryl donor in the
steps involving phosphofructokinase and pyruvate phosphate dikinase during substratelevel phosphorylation [14, 23, 24]. The reaction catalyzed by ACK would thus provide a
source of PPi for these glycolytic enzymes. Furthermore, E. histolytica has been shown to
ferment acetate during growth [14]. Although acetate is produced in the reaction
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catalyzed by ADP-forming acetyl-CoA synthetase, which utilizes ADP for the generation
of ATP from acetyl-CoA [25], ACK may also be responsible for acetate fermentation by
E. histolytica.
Although a physiological role for ACK in acetate and PPi production can be
envisioned, the source of acetyl phosphate as a substrate is unknown. Genes encoding
PTA or XFP, ACK’s known eukaryal partner enzymes, or other known acetyl phosphate
producing enzymes in bacteria are absent in the latest E. histolytica genome assembly.
Three possibilities to explain this are: (i) genes encoding PTA, XFP, or other known
acetyl phosphate-producing enzymes are in unfinished regions of the genome; (ii) a novel
or evolutionarily distinct class of PTA or XFP exists in Entamoeba; and (iii) a previously
uncharacterized or undiscovered acetyl phosphate generating enzyme is present in
Entamoeba species. Lack of XFP or PTA activity in Entamoeba cell extracts argues
against the first two possibilities, although these activities could be labile. In bacteria,
ACK has been shown to play a role in signaling, generating acetyl phosphate for two
component systems or for phosphorylation of CheY and components of the PTS system
[26-29]. However, the kinetic studies presented here do not support such a role.
In conclusion, the Entamoeba ACK is unique among acetate kinases and the
ASKHA enzyme superfamily in its ability to not just utilize PPi/Pi as the phosphoryl
donor/acceptor, but to solely use PPi/Pi to the exclusion of ATP/ADP and other
nucleotide triphosphates/diphosphates. Further examination of the crystal structure of
EhACK and analysis of enzyme variants in both EhACK and MtACK will provide
additional information as to the determinants of this distinctive phosphoryl donor
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specificity. Identification of possible partners for E. histolytica ACK will provide insights
into the function of this unique enzyme and parasite biochemistry.
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Supplemental Figure 3.1S. Loop and wing motifs of the acetate kinase.
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IV. MATERIALS AND METHODS
Cultivation of E. histolytica and cell extract preparation
Trophozoites of E. histolytica strain HM1:IMSS were cultured under axenic
conditions in TYI-S-33 medium [30]. To prepare E. histolytica cell extracts, 4 x 106
trophozoites were resuspended in 25 mM Tris, 150 mM NaCl (pH 7.4) and vortexed with
acid-washed glass beads for one minute followed by one minute on ice, for three cycles.
The extract was centrifuged at 5000 x g for 15 minutes and the supernatant isolated.
Cloning the E. histolytica ACK gene
The gene encoding the E. histolytica ACK was PCR-amplified from E. histolytica
(strain HM1:IMSS) genomic DNA (kindly provided by Lesly Temesvari, Clemson
University) using the primers 5’-GGAACAGGATTCATGTCTAACGTACTAATA-3’
and 5’-GGAACAAAGCTTTTAAAACTGAAATAATTCTTTTTC-3’and cloned into the
E. coli expression plasmid pQE-30 (QIAGEN, Valencia, CA) in-frame with the Nterminal His6 tag sequence using BamHI and HindIII restriction sites incorporated into
the PCR primers. Plasmid DNA was isolated using the Zyppy Plasmid Miniprep Kit
(Zymo Research Corp., Orange, CA). Constructs were confirmed by sequencing
(Clemson University Genomics Institute, Clemson, SC).
Production and purification of recombinant E. histolytica ACK
The Entamoeba ACK expression plasmid was transformed into Escherichia coli
strain YBS121 ΔackApta (kindly provided by George Bennett, Rice University) along
with the lacI-containing plasmid pREP-4 (QIAGEN) for recombinant protein production.
Transformants were grown in LB broth containing 50 µg/ml ampicillin, 34 µg/ml
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chloramphenicol, and 25 µg/ml kanamycin at 37°C/200 RPM to OD600≈0.9. Recombinant
protein production was induced by the addition of isopropyl-β-D-thioglactopyranoside to
1 mM final concentration. Cultures were incubated overnight at ambient temperature/200
RPM and harvested by centrifugation.
Cells were resuspended in breaking buffer (25 mM Tris, 150 mM NaCl, 20 mM
imidazole, 10% glycerol, pH 7.4) and lysed by two passages through a French pressure
cell at 138 MPa. Cellular debris was removed by ultracentrifugation at 100,000 x g for 1
hour and the supernatant was applied to a 5 mL HisTrap® nickel affinity column (GE
Healthcare, Piscataway, NJ). Protein was eluted from the column using a linear gradient
from 0 mM to 500 mM imidazole in 25 mM Tris, 150 mM NaCl, 10% glycerol (pH 7.4).
Fractions containing active enzyme were pooled and dialyzed against buffer containing
25 mM Tris, 150 mM NaCl, and 10% glycerol (pH 7.4). The enzyme was determined to
be electrophoretically pure by SDS-PAGE and Coomassie blue staining.
Protein concentration in cellular extracts and recombinant enzyme preparations
was quantified by the Bradford method [31] using the Bio-Rad Protein Assay with bovine
serum albumin as standard.
Determination of kinetic parameters for EhACK
The hydroxamate assay [17, 32, 33] was used to determine kinetic parameters in
the acetyl phosphate/Pi-forming direction as previously described using a reaction
mixture containing 100 mM MES, 5 mM MgCl2, and 600 mM hydroxylamine
hydrochloride (pH 7.5) with the concentrations of acyl substrate and sodium
pyrophosphate were varied. Reactions were performed at 45°C, the optimal temperature
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for this enzyme. Acetyl phosphate formation was determined by comparison to an acetyl
phosphate standard curve. All assays were performed in triplicate. Kinetic calculations
and progress curves were generated using Kaleidagraph (Synergy Software, Reading,
PA).
Kinetic parameters in the acetate/PPi-forming direction of the reaction were
determined using a modified reverse hydroxamate assay [34]. The reactions contained
100 mM Tris (pH 7.0), 10 mM MgCl2, and varying concentrations of sodium phosphate
and acetyl phosphate. Reactions were performed at 37°C in triplicate. A standard curve of
acetyl phosphate concentrations was used to determine the amount of acetyl phosphate
depleted in the reaction.
To examine the enzymatic mechanism, the enzyme was assayed in the direction
of acetate/PPi formation with varied concentrations of acetyl phosphate (0.5, 0.7, 1.0, and
1.5 mM) and sodium phosphate (40, 50, 60, and 70 mM) as a 4 x 4 matrix. All assays
were performed in triplicate.
Protein crystallization
Crystals of EhACK were grown at 20ºC using the hanging drop vapor diffusion
method by mixing 1.0 μL of 10 mg/ml protein solution with an equal volume of reservoir
solution [50 mM N-(2-acetamido) iminodiacetic acid (ADA) pH 6.6, 0.6 M Na-K
Tartrate, and 10 mM FeCl3] and equilibrating against 1 ml reservoir solution. Crystals
formed in 3 to 5 days and grew to a maximal size of approximately 0.10 × 0.10 × 0.05
mm. Prior to data collection, the EhACK crystals were quickly dragged through a
solution containing 50 mM ADA pH 6.6, 0.8 M Na-K Tartrate, 10 mM FeCl3, and
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30%(w/v) (±)-2-Methyl-2,4-pentanediol (MPD), and were then flash-cooled by plunging
in liquid nitrogen.
X-Ray Data Collection and Processing
X-ray diffraction data were collected on a MAR 225 CCD detector at the Life
Sciences Collaborative Access Team (LS-CAT) beamline 21-ID-G at the Advanced
Photon Source (Argonne, IL) using a wavelength of 0.979 Å and a temperature of 100 K.
Data were processed and scaled using the HKL suite [35], with the best data set merging
to 2.4 Å resolution (Table 3.2). EhACK crystals belonged to the space group I222 with
unit cell dimensions a = 98.8 Å, b = 126.8 Å, c = 145.5 Å, α = β= γ = 90 º.
Structure determination, model building, and refinement
The EhACK structure was determined by molecular replacement using Phaser
2.1 [36] and the coordinates of the M. thermophila acetate kinase dimer [PDB entry 1G99
(ref), 34% sequence similarity] [5] as the search model. Iterative rounds of manual model
building in COOT [37] and refinement in Refmac [38] and CNS [39] were performed to
improve the quality of the model. The final model contains a dimer of EhACK in each
asymmetric unit, which includes residues 2-32 and 39-392 of the A chain, and 2-392 of
the B chain. The refinement achieved reasonable R-factors and geometry (Table 3.2).
Chemicals
Chemicals were obtained from Sigma-Aldrich, ThermoFisher Scientific, or VWR
Scientific Products.
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Table 3.2. Crystallographic data collection and refinement statistics
Data Collection
Beamline

LS-CAT 21-ID-G

Wavelength (Å)

0.979

Space Group

I222
2.4 (2.46 – 2.4)a

Resolution range (Å)
Total reflections

273,804

Unique reflections

35,682

Completeness (%)

99.3 (93.7)

Redundancy

7.7 (5.8)

I/σ

15.6 (3.0)

Rsymb (%)

13.8 (44.0)

Refinement Statistics
Rcryst (Rfree)c (%)

20.9 (24.9)

No. of protein atoms

5,996

No. of solvent atoms

175

No. of ligand atoms

0

Average B factor

38.9

rmsd for bond lengths (Å)

0.018

rmsd for bond angles (°)

2.04

Ramachandran Plot
Most favored (%)

86.5

Additionally allowed (%)

13.5

Generously allowed (%)

0

Disallowed (%)

0
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a

Values in parentheses are values for the highest resolution shell, representing the

resolution range from 2.46 Å to 2.4 Å.
, where I is the intensity and <I> is the weighted mean of I for
N reflections and common indices h,k,l.
.
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CHAPTER IV
SITE-DIRECTED MUTATIONAL ANALYSIS OF ACTIVE SITE RESIDUES IN
THE ACETATE KINASE FROM ENTAMOEBA HISTOLYTICA

Matthew L. Fowler, Cheryl J. Ingram-Smith, and Kerry S. Smith

ABSTRACT
Acetate kinase (ACK) catalyzes the reversible magnesium-dependent synthesis of
acetyl phosphate by transfer of the γ-phosphate of ATP to acetate. A novel PPi-dependent
ACK found in E. histolytica catalyzes a similar reaction through use PPi as the
phosphoryl donor. Using a PPi density generated model of the E. histolytica ACK, a
structure-function approach was utilized to identify residues important for acetatebinding and catalysis. Investigation of the residues in the putative PPi-ACK active site
revealed that while some of the active site residues in the M. thermophila ATP-dependent
ACK are conserved in the E. histolytica enzyme, a number of significant changes to the
active site were found. The residues His117, His172, Val87, Thr201, Thr15, Arg274, and Asp272
appear to be essential for catalysis in the direction of acetate synthesis. Furthermore,
His117 appears to be critically important for binding acetyl phosphate and therefore
important in acetate/PPi synthesis reactions. The data supports the hypothesis that the E.
histolytica ACK operates physiologically in the direction of acetate/PPi synthesis.
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I. INTRODUCTION
Acetate kinase (ACK), an important metabolic enzyme present in all three
domains of life [1], is a member of the acetate and sugar kinase-Hsp70-actin (ASKHA)
enzyme superfamily [2]. This enzyme catalyzes the magnesium-dependent transfer of the
γ-phosphate of ATP to acetate to generate acetyl phosphate. In bacteria and in the
methane-producing archaeon Methanosarcina thermophila, the enzyme partners with
phosphotransacetylase (PTA) in order to generate acetyl-CoA [3]. In fungi, the enzyme
partners with xylulose 5- phosphate/fructose 6- phosphate phosphoketolase (XFP) in a
modified pentose phosphoketolase pathway to catbolize ketose phosphates for the
synthesis of ATP [1]. The enzyme has also been discovered in other eukaryotes such as
Phytophthora spp., Chlamydomonas reinhardtii, and Entamoeba histolytica. In
Phytophthora and C. reinhardtii, ACK partners with PTA to allow for the
interconversion of acetyl phosphate and acetyl-CoA [1, 4].
In 1975, Reeves and Guthrie [5] partially purified a novel pyrophosphate (PPi)dependent ACK in Entamoeba histolytica. This enzyme was capable of utilizing acetyl
phosphate and Pi (Eq. 1) for the synthesis of acetate.
CH3COPO42- + Pi ' CH3COO- + PPi

(Eq. 1)

At the time of the publication, only extracts of E. histolytica could be utilized to study the
enzyme as recombinant techniques for generating large quantities of enzyme were not yet
available. As such, a complete characterization of the PPi-dependent ACK could not be
completed, and only limited information concerning the biochemistry and kinetics of the
enzyme were obtained.
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More recently a biochemical and kinetic characterization of the recombinantly
produced E. histolytica ACK has been completed [6]. Unique among ACKs, E.
histolytica ACK can utilize PPi as a phosphoryl donor but is unable to utilize ATP [6].
The enzyme is also capable of utilizing acyl substrates as long as hexanoate, but prefers
acetate and propionate [6]. As previously hypothesized by Reeves and Guthrie [5] the
enzyme preferentially operates in the direction of acetate synthesis [6]. The recent
structure has also provided additional information on the structural makeup of the active
site of the enzyme [6].
Here we report structure-function analyses of the E. histolytica ACK to identify
amino residues that play key roles in substrate binding and or catalysis. A number of
important residues in the active site of the well-characterized M. thermophila ACK are
not conserved in the E. histolytica ACK. Furthermore, additional residues that play an
important role in acetate binding and catalysis have been discovered. Residues that may
be responsible for phosphoryl donor specificity are noted.
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II. METHODS
Protein sequence analyses
Databases were searched at the National Center for Biotechnology Information
using the BLAST network server [7]. ClustalX was used for multiple protein sequence
alignments [8].
Crystal structure modifications and modeling of variant structures
Structures of the variants were generated using Discovery Studio Modeler®
(Accelrys) from coordinates [6]. Modified structures were modeled using Discovery
Studio ViewerPro® (Accelrys).
Site-directed mutagenesis of the E. histolytica ACK
Site-directed mutagenesis of the genes encoding the E. histolytica and ACK was
performed using the QuickChange® Site-Directed Mutagenesis Kit (Stratagene)
according to the manufacturer’s instructions. All mutagenic primers were 33-35
nucleotides in length with the altered base(s) located at the middle of the sequence. The
altered sequences were confirmed by Sanger-style sequencing at the Clemson University
Genomics Institute (CUGI).
Production and purification of recombinant E. histolytica ACK variants.
Wild-type Entamoeba ACK and its variants were heterologously produced in
Escherichia coli strain YBS121 ΔackApta (kindly provided by George Bennett, Rice
University) along with the lacI-containing plasmid pREP-4 (Qiagen) as described
previously [6]. Transformants were grown in LB broth containing 50 µg/ml ampicillin,
34 µg/ml chloramphenicol, and 25 µg/ml kanamycin at 37°C/200 RPM to OD600≈0.9.
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Recombinant protein production was induced by the addition of isopropyl-β-Dthioglactopyranoside to 1 mM final concentration. Cultures were incubated overnight at
ambient temperature/200 RPM and harvested by centrifugation.
Cells were resuspended in breaking buffer (25 mM Tris, 150 mM NaCl, 20 mM
imidazole, 10% glycerol, pH 7.4) and lysed by two passages through a French pressure
cell at 138 MPa. Cellular debris was removed by ultracentrifugation at 100,000 x g for 1
hour and the supernatant was applied to a 5 mL HisTrap® nickel affinity column (GE
Healthcare, Piscataway, NJ). Protein was eluted from the column using a linear gradient
from 0 mM to 500 mM imidazole in 25 mM Tris, 150 mM NaCl, 10% glycerol (pH 7.4).
Fractions containing active enzyme were pooled and dialyzed against buffer containing
25 mM Tris, 150 mM NaCl, and 10% glycerol (pH 7.4). The enzymes were purified to
apparent homogeneity as judged by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). Protein concentration was quantified by the Bradford
method [9] using the Bio-Rad Protein Assay with bovine serum albumin as standard.
Determination of kinetic parameters for EhACK
The hydroxamate assay [10-12] was used to determine kinetic parameters in the
acetyl phosphate/Pi-forming direction as previously described using a reaction mixture
containing 100 mM MES, 5 mM MgCl2, and 600 mM hydroxylamine hydrochloride (pH
7.5) with the concentrations of acyl substrate and sodium pyrophosphate were varied.
Reactions were performed at 45°C, the optimal temperature for this enzyme. Acetyl
phosphate formation was determined by comparison to an acetyl phosphate standard
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curve. All assays were performed in triplicate. Kinetic calculations and progress curves
were generated using Kaleidagraph (Synergy Software, Reading, PA).
Kinetic parameters in the acetate-forming direction of the reaction were
determined using a modified reverse hydroxamate assay [13]. The reactions (300 µL)
contained 100 mM Tris (pH 7.0), 10 mM MgCl2, and varying concentrations of sodium
phosphate and acetyl phosphate. Reactions were pre-incubated for 1 minute at 37°C,
initiated by the addition of purified enzyme or native E. histolytica extract and terminated
by the addition of 50 µL 2 M hydroxylamine hydrochloride (pH 7.0). Following
incubation at 60°C for 5 minutes, 100 µL 500 mM FeCl3, 3 N HCl, 30 % trichloroacetic
acid or 500 mM FeCl3, 7 N HCl, 50 % trichloroacetic acid was added for color
development and the absorbance at 540 nm was measured spectrophotometrically. All
assays were performed in triplicate. A standard curve of acetyl phosphate concentrations
was used to determine the amount of acetyl phosphate consumed in the reaction.
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III. RESULTS AND DISCUSSION
Production and purification of variant acetate kinases.
Val87, Thr223, Ile116, Ser230, Ser271, Thr15, Thr201, Asp272, Arg274, His117, His172 and
Glu323 in the E. histolytica ACK were subjected to site-specific replacement to test the
hypothesis that these residues are involved in substrate binding and/or catalysis (Figure
4.1). The residues selected were identified from multiple amino acid sequence alignments
of ACKs from M. thermophila and other prokaryotic and eukaryotic microbes, and from
preliminary E. histolytica structures and models.
Kinetic characterization of putative acyl pocket residues.
The most prominent difference between residues found in the acetate pocket of
the well-characterized M. thermophila ACK to that of E. histolytica ACK is the presence
of a threonine at position 223, corresponding to a proline at position 232 in the M.
thermophila enzyme (Figure 4.1). Pro232 is involved in substrate positioning and catalysis
in the acetate binding pocket of the M. thermophila ACK [14]. Alteration of Thr223 to
proline for the E. histolytica ACK had little effect on the kinetic parameters as the
enzyme remained capable of utilizing substrates as long as hexanoate (Table 4.1).
Furthermore, kinetic parameters for PPi were also not significantly altered (Table 4.2). In
the direction of acetate formation, no significant changes in the kinetic parameters for
acetyl phosphate were observed for the Thr223Pro variant (Table 4.3). The Thr223Gly
variant did not display activity for any acyl substrate in the acetyl phosphate-forming
direction. A specific activity of 285.9 ± 0.1 µmol min-1 mg-1 was determined for the
Thr223Gly variant in the acetate-forming direction at 0.6 mM acetyl phosphate in
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comparison to the wild type specific activity of 1368.9 ± 0.1 µmol min-1 mg-1, but kinetic
parameters could not be determined as the enzyme could not be saturated with
pyrophosphate.
Variant Thr223Ala was produced as an inactive and insoluble enzyme. Changes to
this residue likely resulted in the addition of a side chain residue that disrupted proper
folding of the enzyme. The Thr223Gly variant lacks a true side chain, and the resulting
enzyme structure properly folded.
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Ehistolytica
Einvadens
Pramorum
Pnodorum
Cneoformans
Ecoli
Mthermophila

Ehistolytica
Einvadens
Pramorum
Pnodorum
Cneoformans
Ecoli
Mthermophila

1
1
27
2
5
3
1

112
112
146
126
129
118
118

8 11 15
MSNVLIFNVGSSSLTYKVF
MPHILVFNVGSSSLTYKLF
DSHLLVINAGSSSLKYSLF
SEIILSINAGSSSVKISVY
TEYLLAINCGSSSIKGKLF
SKLVLVLNCGSSSLKFAII
-MKVLVINAGSSSLKYQLI
7 10 14
116/117
PLAPIHNPSSF
PLAPIHNPASY
KLAPLHNPGNL
DLAPLHNGPAL
EFAPLHNHRAV
SFAPLHNPAHL
ELAPLHNPPNM
122/123

216
216
253
233
237
227
225

81
81
115
96
96
87
87

84 87
FVGHRFVHGGS
IVGHRFVHGGS
AVGHRVVHGGE
FTCHRVVHGGD
YVCHRVVHGGT
AIGHRIVHGGE
AVGHRVVHGGE
90 93

223
232
DTSMGNSTLAGLVMSTRCGDID
DTSMGNSTLAGLVMSTRCGDID
DTSMGMTPLEGLVMGTRSGDID
DTSMGLTPLAGLPGATRSGSID
DTSMGLTPLEGLLGGTRSGTID
DTSMGLTPLEGLVIGTRSGDID
ETSMGFTPLEGLAMGTRCGSID
232
241

Figure 4.1. Sequence alignment of important residues in ACK from Eukarya, Bacteria,
and Archaea. Residues that have been identified as being important for either acetatebinding (red) or catalysis (blue) in the M. thermophila ACK are highlighted. Differences
in the E. histolytica active site are noted in green. Residue numbers above the alignments
are of E. histolytica ACK and below the alignments are of M. thermophila ACK.
Entamoeba histolytica, Ehistolytica; Entamoeba invadens, Einvadens; Phytophpthora
ramorum, Pramorum; Phaeosphaeria nodorum, Pnodorum; Cryptococcus neoformans,
Cneoformans; Escherichia coli, Ecoli; Methanosarcina thermophila, Mthermophila.
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Table 4.1. Kinetic parameters for the wild type and Thr223Pro variant for acetate in the
direction of acetyl phosphate synthesis.
Acetate
Enzyme/Substrate

kcat (s-1)

Km (mM)

kcat/Km (s-1 mM-1)

wild type
acetate

106.8

±

1.00

1.8

±

0.01

0.016

±

0.001

propionate

79.8

±

1.94

1.2

±

0.01

0.015

±

0.001

butyrate

75.6

±

1.49

0.33

±

0.01

0.0043

±

0.0001

valerate

56.7

±

0.67

0.19

±

0.01

0.0034

±

0.0001

hexanoate

20.5

±

0.49

0.051

±

0.001

0.0025

±

0.0001

169.5

±

0.06

1.3

±

0.01

0.23

±

0.01

propionate

98.7

±

0.18

0.61

±

0.01

0.0062

±

0.0001

butyrate

56.5

±

0.46

0.18

±

0.01

0.0032

±

0.0001

valerate

41.6

±

0.25

0.21

±

0.01

0.0049

±

0.0001

hexanoate

20.4

±

0.52

0.065

±

0.001

0.0032

±

0.0001

Thr232 Pro
acetate
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Table 4.2. Kinetic parameters for the wild type and Thr223Pro variant for PPi in the
direction of acetyl phosphate synthesis.
PPi
Enzyme/Substrate

kcat (s-1)

Km (mM)

kcat/Km (s-1 mM-1)

wild type
acetate

3.6

±

0.1

3.9

±

0.1

1.1

±

0.02

propionate

4.8

±

0.4

2.6

±

0.1

0.54

±

0.02

butyrate

3.2

±

0.1

0.029

±

0.001

0.09

±

0.01

valerate

6.3

±

0.1

0.051

±

0.001

0.081

±

0.001

16.3

±

0.4

0.032

±

0.001

0.019

±

0.001

acetate

6.3

±

0.1

2.0

±

0.01

0.32

±

0.01

propionate

4.0

±

0.1

1.1

±

0.01

0.17

±

0.01

butyrate

4.9

±

0.1

0.73

±

0.01

0.15

±

0.01

valerate

3.0

±

0.1

0.29

±

0.01

0.097

±

0.001

hexanoate

1.9

±

0.1

0.081

±

0.001

0.043

±

0.001

hexanoate

Thr22 Pro
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Table 4.3. Kinetic parameters for acetyl phosphate for wild-type and variant ACKs
assayed in the direction of acetate synthesis.
Acetyl phosphate
Enzyme

kcat (s-1)

Km (mM)

kcat/Km (s-1 mM-1)

wild type

0.50

±

0.006

1938.8

±

13.7

3845.6

±

68.9

Thr223Pro

2.00

±

0.082

8332.9

±

185.4

4260.5

±

82.7

Thr223Gly

*

*

*

Ile116Ala

1.6

±

0.094

279.9

±

2.0

174.9

±

8.9

Ile116Leu

2.4

±

0.023

343.81

±

2.1

143.8

±

0.73

Ser230Ala

4.5

±

0.059

2181.0

±

7.0

485.9

±

5.1

Ser230Gly

1.2

±

0.038

1115.6

±

10.0

911.3

±

19.9

Thr15Ala

1.1

±

0.029

988.3

±

9.5

896.1

±

15.3

Thr15Lys

1.1

±

0.044

21.2

±

0.25

19.0

±

0.55

Val87Ala

0.53

±

0.027

120.8

±

1.6

226.7

±

10.1

Val87Gly

0.51

±

0.017

96.9

±

0.96

188.7

±

4.4

Ser271Ala

1.0

±

0.028

953.5

±

6.6

916.0

±

18.4

Ser271Asn

0.58

±

0.013

253.2

±

0.87

436.5

±

9.3

Thr201Ala

1.7

±

0.059

32.2

±

0.29

18.5

±

0.50

Thr201Asn

1.2

±

0.079

5.6

±

0.06

4.6

±

0.24

Asp272Asn

0.71

±

0.03

13.7

±

0.13

19.3

±

0.64

Asp272Glu

*

*

*

Asp272Ala

*

*

*

Arg274Ala

0.56

±

0.019

14.3

±

0.13

25.9

±

0.74

His117Ala

8.0

±

0.072

20.5

±

0.07

2.6

±

0.02

His172Ala

0.69

±

0.074

2.0

±

0.07

2.8

±

0.25

* unable to determine kinetic parameters due to low activity
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Although the E. histolytica ACK Thr223Ala variant was insoluble, an alanine change at
the corresponding Pro232 residue in M. thermophila results in a soluble enzyme with a
significantly decreased turnover (26-fold) and catalytic efficiency (126-fold) compared to
the wild type [14]. This change in solubility of the enzyme for variant changes indicates a
structural variation between these ACKs which is reinforced by these different residues.
In the M. thermophila ACK, a leucine is present at position 122 which
corresponds to Ile116 in the E. histolytica ACK. Leu122 has been shown to play an
important role in acetate binding [14] and is hypothesized to stabilize the methyl group of
acetate in the M. thermophila ACK [15]. The Ile116Ala variant displayed insignificant
changes in kinetics for acetate compared with the wild type kinetic parameters. However,
the Ile116Leu variant displayed a 25-fold decrease in the kcat and 34-fold decrease in the
overall enzyme efficiency for acetate compared to the wild type ACK (Table 4.4). Both
the Ile116A and Ile116Leu variants were unable to utilize longer acyl substrates. A 26-fold
decrease in kcat and 24-fold decrease in enzyme efficiency for PPi assayed with acetate
were observed for the Ile116Ala variant (Table 4.5). Kinetic parameters for PPi assayed
with acetate could not be determined for the Ile116Leu variant due to low activity.
Significant decreases for both the kcat and enzyme efficiency for acetate indicate that
Ile116 plays an important for catalysis. In the direction of acetate formation, marked
decreases of 22-fold and 27-fold in the catalytic efficiency were observed for both
Ile116Ala and Ile116Leu respectively (Table 4.3). The decreases in catalytic efficiency for
acetyl phosphate as well as the decreases in the turnover and catalytic efficiency in the
acetate forming directions for these variants further implicates Ile116 as important for
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catalysis. Whereas the Leu122 in the M. thermophila ACK plays a role in acetate binding,
Ile116 in the E. histolytica enzyme has a role in catalysis.
Val87 in the E. histolytica ACK corresponds to Val93 in the M. thermophila ACK,
which has been shown to be important for acetate binding [14] by providing stabilization
to the methyl group of acetate [15]. The Val87Ala and Val87Gly variants were not active
in the acetyl phosphate-forming directions and therefore kinetic parameters were unable
to be determined. Loss of the more prevalent hydrophobic interaction indicates that this
residue plays an important role in the active site of the E. histolytica ACK. Significant
decreases in turnover and catalytic efficiency were observed for Val87Ala and Val87Gly in
the direction of acetate synthesis (Table 4.3). 91-fold and 16-fold decreases in turnover
and 202-fold and 16-fold decreases in catalytic efficiency were observed for Val87Ala and
Val87Gly respectively. These significant decreases in the direction of acetate synthesis
indicate that Val87 plays an important role in catalysis. Val87 is located in a hydrophobic
pocket of the putative active site with another hydrophobic residue (Phe117) at a distance
of only 4.3 Å. These residues may also participate in hydrophobic interactions with the
methyl group of acetate and acetyl phosphate in the E. histolytica ACK.
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Table 4.4. Kinetic parameters for acetate for wild-type and variant ACKs assayed in the
direction of acetyl phosphate synthesis.
Acetate

Enzyme

Km (mM)

wild type

106.8

±

1

Ile116Ala

219.6

±

Ile116Leu

146.2

Ser230Ala

kcat (s-1)

kcat/Km (s-1 mM-1)

1.8

±

0.01

0.016

±

0.001

9.9

0.88

±

0.01

0.004

±

0.001

±

5.3

0.069

±

0.001

0.00047

±

0.00001

142.6

±

9.8

0.84

±

0.013

0.0059

±

0.0003

Ser230Gly

145.9

±

1.7

0.57

±

0.001

0.0039

±

0.0001

Thr15Lys

59.1

±

6.6

0.27

±

0.001

0.0045

±

0.0001

Thr15Ala

114.0

±

0.85

0.61

±

0.001

0.0054

±

0.0001

Ser271Asn

140.3

±

2.8

0.16

±

0.001

0.0012

±

0.0001

Arg274Ala

186.4

±

21.7

0.11

±

0.003

0.00056

±

0.00005

Ser271Ala

173.7

±

0.92

0.93

±

0.01

0.0054

±

0.0001

144

Table 4.5. Kinetic parameters for PPi for wild-type and variant ACKs assayed in the
direction of acetyl phosphate synthesis in the presence of acetate.
PPi

Enzyme

kcat (s-1)

Km (mM)

kcat/Km (s-1 mM-1)

wild type

3.9

±

0.1

3.6

±

0.1

1.1

±

0.02

Ile116Ala

0.2

±

0.01

3.3

±

0.1

0.043

±

0.001

Ser230Ala

1.1

±

0.01

1.4

±

0.1

0.78

±

0.01

Ser230Gly

1.2

±

0.01

5.2

±

0.1

0.23

±

0.01

Thr15Ala

0.73

±

0.01

3.3

±

0.1

0.22

±

0.01

Ser271Asn

0.22

±

0.01

1.1

±

0.1

0.20

±

0.01

Arg274Ala

0.23

±

0.01

2.8

±

0.1

0.085

±

0.001

Ser271Ala

1.3

±

0.01

5.7

±

0.1

0.22

±

0.01
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Characterization of other catalytically important residues.
A lysine at position 14 in the M. thermophila ACK has been shown to be
catalytically important in the active site, acting as a site for hydrogen bonding during
substrate interaction [14]. Lys14 corresponds to Thr15 in the E. histolytica enzyme. With
acetate as the acyl substrate, alteration of Thr15 to alanine resulted in a 12-fold increase in
kcat, but did not significantly alter other kinetic parameters (Table 4.4). Kinetic
parameters for propionate were not significantly altered (Table 4.6), but information on
longer acyl chain substrates could not be garnered due to loss of activity. No significant
changes in the kinetic parameters for acetyl phosphate were observed for the Thr15Ala
variant in the acetate forming direction. However, 91-fold and 202-fold decreases in
turnover and catalytic efficiency of acetyl phosphate were observed for the Thr15Lys
variant in the direction of acetate synthesis (Table 4.3).
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Table 4.6. Kinetic parameters for propionate for wild-type and variant ACKs assayed in
the direction of acetyl phosphate synthesis.
Propionate

Enzyme

kcat (s-1)

Km (mM)

kcat/Km (s-1 mM-1)

wild type

79.8

±

1.94

1.2

±

0.005

0.015

±

0.0003

Thr223Pro

98.7

±

0.18

0.61

±

0.001

0.0062

±

0.00001

Ser230Ala

104.4

±

4.19

0.36

±

0.003

0.0034

±

0.0001

Ser230Gly

128.4

±

0.05

0.36

±

0.001

0.0028

±

0.00001

Thr15Ala

108.8

±

0.98

0.26

±

0.001

0.0024

±

0.00002

Ser271Asn

64.4

±

0.82

0.058

±

0.001

0.00091

±

0.00001

Ser271Ala

101.5

±

0.60

0.33

±

0.0002

0.0032

±

0.00002
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The change in observed kinetic parameters as compared to those of the
corresponding Lys14 residue in the M. thermophila enzyme, imply that Thr15 in the E.
histolytica ACK may have a different role from its archaeal Lys14 counterpart.
Theoretically, the Thr15Lys variant would result in lysine protruding into the core of the
putative active site, likely interfering with catalysis (Figure 4.2). The Thr15 residue is
located on the periphery of the putative active site and likely plays a role in catalysis
upon close of the active site.
In the M. thermophila ACK, His180 plays an important role in catalysis [16], and
is hypothesized to interact with the α-phosphate of ATP during acetyl phosphate
synthesis by stabilizing the transition state [15]. When the corresponding residue in E.
histolytica (His172) was altered to alanine activity in the acetyl phosphate-forming
direction could not be detected. In the direction of acetate formation a 995-fold and 1354fold decrease in respective turnover and catalytic efficiency for acetyl phosphate was
observed for His172Ala (Table 4.3). This significant decrease in turnover and enzyme
efficiency indicates that this residue is critical for catalysis. The His172 residue lies
directly in the core of the active site, providing one or more hydrogen atoms from the
imidazole ring of histidine as lone pair acceptors. Alteration of this residue to alanine
would theoretically remove this residue from the core of the putative active site,
providing only limited, if any, hydrophobic interaction with the substrates.
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Figure 4.2. The putative active site of the E. histolytica ACK. Residues important for
acetate binding and catalysis (turquoise). Residues that may interact with substrates upon
closure of the active site (red). The putative active site is modeled from data received
from the laboratory of Dr. Tina Iverson, Vanderbilt University [6].
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His123 is located near the active site in the M. thermophila ACK and has been
reported to be important for acetyl phosphate binding [16]. When the corresponding
His117 in the E. histolytica enzyme was changed to alanine, acetyl phosphate synthesis
could not be detected. In the direction of acetate synthesis the His117Ala variant displayed
a 16-fold increase in the Km for acetyl phosphate, indicating that this residue may be
important for acetyl phosphate binding (Table 4.3). Furthermore, a 95-fold and 1496-fold
decrease in respective turnover and catalytic efficiency for acetyl phosphate was
observed for His117Ala. This significant decrease implicates this residue‘s importance in
catalysis. This residue lies near the core of the putative active site (Figure 4.2), and like
His172, may provide hydrogen atoms for electrons from an oxygen located one or more of
the phosphate groups of Pi or PPi. The His117Ala variant would result in removal of these
lone pair acceptors and the resulting methyl group side chain would likely be so far
removed from the core of the putative active site that interaction with ACK substrates
would no longer be possible.
Characterization of other possible active site residues.
The E. histolytica ACK was crystallized in the presence of PPi and an electron
density found to be present within the structure was originally modeled as PPi (Figure
4.3). However, further refinement suggests that PPi is not present in the structure.
Residues Ser230, Ser271, Asp272, Arg274, and Thr201 were hypothesized to participate in PPi
binding and/or catalysis in the initial structure. Protein sequence alignments comparing
the corresponding residues in the M. thermophila, E. coli, and fungal ACK sequences
indicate a number of these changes are unique to the Entamoeba enzymes (Figure 4.4).
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Figure 4.3. An early model of the active site of the E. histolytica ACK. Residues Ser230,
Ser271, Asp272, Arg274, and Thr201 are hypothesized to participate in PPi binding and/or
catalysis. Structure image produced by Tarjani Thaker and Dr. Tina Iverson, Vanderbilt
University.
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To investigate the roles of these residues in the E. histolytica ACK, each of the above
residues was changed to either alanine or the corresponding amino acid found in the M.
thermophila ACK.
Ser230Ala and Ser230Gly variants did not display significant changes in kinetic
parameters for acetate (Table 4.4), or PPi (Table 4.5), or propionate (Table 4.6).
However, parameters for longer acyl chain substrates could not be determined due to loss
of activity. No significant changes in the kinetic parameters for acetyl phosphate were
observed for either variant.
Another serine residue (Ser271) is located adjacent to Ser230 in the putative active
site (Figure 4.4). Variants Ser271Ala and Ser271Asn had insignificant changes in their
kinetic parameters for acetate with exception to Ser271Asn which displayed a 10-fold
decrease in enzyme efficiency in acetyl phosphate synthesis (Table 4.4). A 17-fold
decrease in the kcat for PPi was observed for acetyl phosphate synthesis (Table 4.5). Both
Ser271Ala and Ser271Asn were unable to utilize acyl substrates longer than propionate. A
30-fold decrease in the kcat and 17-fold decrease in enzyme efficiency was observed for
Ser271Asn for propionyl phosphate synthesis (Table 4.6). No significant changes in
kinetic parameters were observed for Ser271Ala and Ser271Asn in the direction of acetate
synthesis.
In the refined structure, Ser230 and Ser271 are located on the margins of the
putative active site and would appear to have little to no interaction with acetyl phosphate
(Figure 4.2). However, changes to these residues had an effect on propionate and longer
acyl substrates during acetate synthesis. The absence of activity of substrates longer than
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propionate can be attributed to the use of high concentrations of protein in the assay to
detect ACK activity in the direction of acetate synthesis. The use of such high
concentrations of protein is necessary for the detection of ACK activity in this direction
and is likely the reason that Reeves and Guthrie [5] were unable to detect acetyl
phosphate forming ACK activity more than 35 years earlier.
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198 201
IACHLGTGGSS
VACHLGTGGSS
VTCHLGNG-SS
VALHLGSG-AS
VVAHLGSG-SS
ITCHLGNG-GS
ITCHLGNG-SS
208 211

Ehistolytica
Einvadens
Pramorum
Pnodorum
Cneoformans
Ecoli
Mthermophila

195
195
233
213
217
207
205

Ehistolytica
Einvadens
Pramorum
Pnodorum
Cneoformans
Ecoli
Mthermophila

271/272/274
270 SSDMRDILH
270 SCDIRDLLK
308 ESDIRVIQD
298 TTDFGKISS
299 TTNFGHIIQ
283 TSDCRYVED
281 SNDFRDLDE
282/283/285

226
226
263
243
247
237
235

320
320
357
342
358
330
328

230
GLVMSTRCGDID
GLVMSTRCGDID
GLVMGTRSGDID
GLPGATRSGSID
GLLGGTRSGTID
GLVIGTRSGDID
GLAMGTRCGSID
239
323 327
FTDQMGLEVWQV
FTDQVGLEVPEV
FTAGIGESSAMI
FAGGIGEKGDRL
FSGGIGEKGAEL
FTGGIGENAAMV
FTAGIGENSASI
331 335

Figure 4.4. Alignment of sequences identified from early analysis of the E. histolytica
structure along with corresponding residues from other Eukarya, Bacteria, and Archaea.
Residues proposed to play a role in either ATP binding and catalysis in the M.
thermophila ACK are highlighted in green. Active site residue differences in the
Entamoeba ACKs (blue) and fungal ACKs (red) are noted. Residue numbers above the
alignments are of the E. histolytica ACK. Residue numbers below the alignments are of
the M. thermophila ACK. Entamoeba histolytica, Ehistolytica; Entamoeba invadens,
Einvadens; Phytophpthora ramorum, Pramorum; Phaeosphaeria nodorum, Pnordorum;
Cryptococcus neoformans, Cneoformans; Escherichia coli, Ecoli; Methanosarcina
thermophila, Mthermophila.
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Thr201 in the E. histolytica ACK was altered to alanine and asparagine. Both the
Thr201Ala and Thr201Asn variants were not active in the acetyl phosphate-forming
direction indicating that these residues may play an important role in the active site. In
the direction of acetate synthesis, significant decreases in both the kcat and catalytic
efficiency for acetyl phosphate were observed for both variants. A 60-fold and 343-fold
decrease in the kcat were observed for Thr201Ala and Thr201Asn respectively (Table 4.3).
Decreases of 207-fold and 837-fold in catalytic efficiency were respectively observed for
Thr201Ala and Thr201Asn. These significant decreases in both enzyme turnover and
catalytic efficiency for acetyl phosphate indicate that this residue plays an important role
in catalysis, most especially in the direction of acetate formation. Thr201 projects the
methyl group of the side chain into the core of the putative active site; which leads to the
hypothesis that this residue may provide some hydrophobic interaction during catalysis
(Figure 4.2). The Thr201Ala variant contains a truncated side chain in comparison to the
wild type enzyme, reducing the hydrophobic interaction in this region of the putative
active site, and would theoretically point in a direction perpendicular to the direction of
the methyl group of threonine at this position. Thr201Asn variant alters the
hydrophobicity, and likely ejects a polar side chain into the putative active site. The
significant decreases in both catalysis and catalytic efficiency noted above for the
Thr201Asn variant, but less significant for the Thr201Ala variant support the presence of a
hydrophobic side chain interacting with one or more of the substrates utilized by the
enzyme. Thr201 could also participate in hydrogen bonding with one or more of the ACK
substrates.
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Asp272 was altered to asparagine, glycine, and alanine. The variants were not
active in the acetyl phosphate-forming direction indicating that this residue may be
important for acetate and/or PPi binding or catalysis. Furthermore, the Asp272Asn variant
displayed significant decreases of 142-fold and 200-fold turnover and catalytic efficiency
for acetyl phosphate in the direction of acetate formation (Table 4.3). Aspartate variants
Asp272Asn and Asp272Gly displayed specific activities too low to determine kinetics. The
significant decreases in turnover and catalytic efficiency for the Asp272Asn variant and
extremely low specific activity for Asp272Ala and Asp272Gly in the direction of acetate
synthesis implies that this residue plays an important role in catalysis. This residue may
be important in enzyme folding or in structural integrity of the putative active site. The
aspartate residue faces away from the internal portion of the putative active site, and
therefore, would not be hypothesized to participate in substrate interaction (Figure 4.2).
In the M. thermophila ACK, Arg285 is involved in binding acetate [17] and the
corresponding residue Arg274 is also near putative acetate pocket in the E. histolytica
active site. An Arg274Ala variant displayed a 16-fold and 17-fold decrease in kcat for
acetate (Table 4.4) and PPi respectively (Table 4.5). The enzyme efficiencies for acetate
and PPi were also decreased by 28-fold and 12-fold, respectively. The Arg274Ala variant
was unable to use longer acyl substrates. In the direction of acetate synthesis a 135-fold
and 148-fold decrease in respective turnover and catalytic efficiency were observed for
acetyl phosphate (Table 4.3), implying that this residue may be important for catalysis.
The decreases observed in the acetyl phosphate forming direction for PPi combined with
the decreases observed in the kinetic parameters for acetyl phosphate in acetate synthesis

156

highlights that this residue may interact with one or more of the phosphates of PPi and/or
acetyl phosphate. One, if not both of the amine groups of Arg274 face into the active site,
allowing for one or more of the hydrogen atoms a part of the amine to act as a lone pair
acceptor (Figure 4.2). The truncated side chain in the Arg274Ala variant would be
hypothesized to no longer interact with substrates in the putative active site due to
distance from the site core. While, Arg285 in the M. thermophila ACK plays a role in
acetate-binding, the corresponding Arg274 residue in the E. histolytica enzyme is involved
in catalysis.
Conclusions.
Kinetic analyses of ACKs variants identified from sequence alignments have
resulted in the identification of residues important for acetate and acetyl phosphate
binding, and catalysis. Furthermore, a number of residues that may be important for PPibinding have also been identified.
Multiple attempts were made to generate variants of Glu323, but site specific
changes could not be generated at the DNA level possibly due to primer interactions or
temperature annealing problems.
While a number of important residues have been identified, additional residues
that have been identified in both sequence alignments (Figure 4.1 and Figure 4.3) and in
recent refined structures [6] should be further investigated. Ser11, Ser12, Ser13, and Asn8
are located in the margins of the putative active site and may provide sites for interaction
with phosphate oxygen atoms. His198 and Arg232 protrude into the core of the putative
active site, and their close proximity to other residues that have been shown to be

157

important in catalysis implicates them as candidates for site specific changes. The results
presented here have not only broadened our understanding of the ACK enzyme family
but have provided a foundation for future investigations.
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CHAPTER V
RNA INTERFERENCE AND THE PHYSIOLOGICAL ROLE OF THE
ACETATE KINASE IN ENTAMOEBA HISTOLYTICA

Matthew L. Fowler, Madison A. Foster, Ann M. Guggisberg, Cheryl J. IngramSmith, and Kerry S. Smith

ABSTRACT
Entamoeba histolytica is a protozoan parasite and the third leading cause of
parasitic morbidity and mortality worldwide. The enzyme acetate kinase (ACK), a
prokaryotic metabolic enzyme, has recently been discovered in several eukaryotic
organisms, including E. histolytica. In prokaryotes, ACK catalyzes the reversible
phosphorylation of acetate to acetyl phosphate utilizing ATP. The ACK identified in E.
histolytica differs from the prokaryotic ACK in that the enzyme uses pyrophosphate (PPi)
in place of ATP as the phosphoryl donor. Common partners for ACK,
phosphotransacetylase (PTA) and xylulose 5-phosphate/fructose 6-phosphate
phosphoketolase (XFP) are also absent in the current E. histolytica genome assembly.
Here, the dependency of the PPi-dependent ACK from E. histolytica is investigated. Short
hairpin RNA interference constructs were generated in order to post-transcriptionally
knock down the expression of the E. histolytica PPi-ACK. Specific activities from
purified E. histolytica extracts indicate that the enzyme functions in the direction of
acetyl phosphate formation, suggesting a physiological means of generating PPi. The
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introduction of plasmid DNA into E. histolytica was unsuccessful in these experiments.
However, the results here will be important for future attempts at gene knockdown and
investigations into parasite dependency on this enzyme. Further knowledge of the
dependency of metabolic enzymes in E. histolytica may lead to new drug targets and
treatments of amoebic dysentery.
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I. INTRODUCTION
Entamoeba histolytica is a protozoan parasite and the causative agent of amoebic
dysentery. Affecting nearly 50 million people worldwide, E. histolytica is the third
leading cause of death world-wide due to parasitic disease resulting in more than 100,000
deaths annually [1]. Infection of the host is accomplished through the fecal-oral route.
Contaminated food or water is ingested which contain quadra-nuclear cysts. Once these
cysts reach the lumen of the small intestine, the cysts undergo excystation, resulting in
the production of the amoebic trophozoites. These mobile parasites can then disseminate
to other organs such as the liver, lungs, or brain and generate abscesses which result in a
high rate of mortality [2]. Trophozoites can undergo encystation in the large intestine
where they are passed into the feces (Figure 5.1) [3].
Initially thought to be present only in prokaryotes, ACK has been identified in the
genomes of several eukaryotes, including E. histolytica [4]. ACK functions in the
interconversion of acetate to acetyl phosphate with ATP as the phosphoryl donor and is
an important enzyme in bacterial and archaeal metabolism for the synthesis of acetylCoA [4-6]. In many prokaryotes, and more recently discovered in eukaryotes such as
Phytophthora spp. and Chlamydomonas reinhardtii, a partner enzyme
phosphotransacetylase (PTA) is responsible for the interconversion of acetyl phosphate to
acetyl-CoA[4]. In fungi, another bacterial enzyme xylulose 5-phosphate/fructose 6phosphate phosphoketolase (XFP), has been proposed to partner with ACK to convert
xylulose 5-phosphate or fructose 6-phosphate to acetate for the generation of ATP [4].
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Figure 5.1. Life cycle of E. histolytica. The mature cyst is ingested by the human host.
Excystation of the cyst occurs in the small intestine where the active trophozoite is
produced. The trophozoite can then replicate by binary fission to form additional
trophozoites, or can undergo encystation to produce a number of cysts. Cysts are passed
into the host’s feces where water-borne transmission allows for continuation of the
parasite’s life cycle. Taken from [3].

165

Previous research on E. histolytica has led to the discovery of an ACK in the
parasite [7]. The enzyme is novel among other known ACKs in that the enzyme utilizes
PPi as the phosphoryl donor in the place of ATP [8]. Furthermore, this ACK is unique in
that it is capable of utilizing acyl substrates longer than butyrate. [8]. The enzyme
displays 3,500-fold difference in catalytic efficiency in the direction of acetate formation
indicating preferential directionality for acetate and PPi formation. Acetyl phosphate
could be generated from either XFP or PTA, partners for ACK in other eukaryotes.
However, genes encoding either enzyme are absent in the most recent genome assembly.
We are currently investigating the role of the PPi-dependent ACK in E.
histolytica. An acetate-forming PPi-ACK activity was detected in cellular extracts, but an
ATP-ACK activity was not. Activities for PTA and XFP, the proposed partners for ACK
in other eukaryotes, were also not detected in cellular extracts of the parasite. Here we
describe an attempt at short hairpin RNA (shRNA) interference in E. histolytica in order
to down-regulate expression of the enzyme. The introduction of shRNAs into the parasite
is expected to target and inhibit expression of the ACK. While we were unable to
successfully perform this technique as previously described [9, 10], the results of RNAi
experiments are important for the future development of this system and determination of
the importance of this enzyme in the parasite’s metabolic processes. In addition, the
human host lacks an ACK, implicating this gene as a possible target for the development
of new treatments for infection by E. histolytica.
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II. MATERIAL AND METHODS
Cultivation of E. histolytica
Trophozoites of E. histolytica strain HM1:IMSS were routinely cultured under
axenic conditions in TYI-S-33 medium [11].
Cell extract preparation
To prepare E. histolytica cell extracts, 4 x 106 trophozoites were resuspended in
25 mM Tris, 150 mM NaCl (pH 7.4) and vortexed with acid-washed glass beads for one
minute followed by one minute on ice, for three cycles. The extract was centrifuged at
5000 x g for 15 minutes and the supernatant isolated.
Hydroxamate assay for ACK activity
The hydroxamate assay [5, 12, 13] was used to determine kinetic parameters in
the acyl phosphate-forming direction. The reactions (300 µL) contained 100 mM MES, 5
mM MgCl2, 600 mM hydroxylamine hydrochloride (pH 7.5), 2 M acetate and 10 mM
sodium pyrophosphate. ATP and PPi were tested as substrates at a final concentration of
10 mM. The reactions were pre-incubated at 45°C for 1 minute and initiated by the
addition of enzyme. Reactions were terminated by the addition of two volumes of 1.25%
FeCl3, 1 N HCl, 5% trichloroacetic acid and the absorbance at 540 nm was measured
spectrophotometrically. All assays were performed in triplicate. Kinetic calculations and
progress curves were generated using Kaleidagraph (Synergy Software, Reading, PA).
Kinetic parameters in the acetate-forming direction of the reaction were
determined using a modified reverse hydroxamate assay [14]. The reactions (300 µL)
contained 100 mM Tris (pH 7.0), 10 mM MgCl2, 200 mM sodium phosphate, and 2 mM
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acetyl phosphate. Reactions were pre-incubated for 1 minute at 37°C, initiated by the
addition of purified enzyme or native E. histolytica extract and terminated by the addition
of 50 µL 2 M hydroxylamine hydrochloride (pH 7.0). Following incubation at 60°C for 5
minutes, 100 µL 250 mM FeCl3, 1.5 N HCl, 15 % trichloroacetic acid was added for
color development and the absorbance at 540 nm was measured spectrophotometrically.
All assays were performed in triplicate. A standard curve of acetyl phosphate
concentrations was used to determine the amount of acetyl phosphate depleted in the
reaction.
Phosphotransacetylase (PTA) assay
Activity was measured in both the acetyl phosphate-forming and the acetyl-CoAforming directions by monitoring the decrease or increase in absorbance at 233 nm for 20
minutes in triplicate, indicative of the formation or breakage of the thioester bond of
acetyl-CoA, respectively. The reaction mix for the acetyl phosphate-forming assay [6]
consisted of 100 mM Tris (pH 7.0), 2 mM DTT, 10 mM sodium phosphate, and 120 µg
of native E. histolytica extract in a total volume of 200 µL. The reaction was initiated by
the addition of acetyl-CoA (0.5 mM final concentration). The reaction mix for the acetylCoA-forming assay consisted of 100 mM Tris (pH 7.0), 2 mM DTT, 0.5 mM CoA, and
120 µg of native E. histolytica extract in a total volume of 200 µL. The reaction was
initiated by the addition of acetyl phosphate (2 mM final concentration).
Xylulose 5-phosphate/fructose 6-phosphate phosphoketolase (XFP) assay
XFP activity in E. histolytica cell extracts was analyzed using the hydroxamate
assay to detect the formation of acetyl phosphate [5, 12, 13]. The reaction mix contained
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100 mM Tris, 600 mM hydroxylamine hydrochloride, 2 mM DTT, and 100 mM fructose
6-phosphate (pH 7.0) in a total volume of 300 µL. The reaction was initiated by the
addition of 120 µg of native E. histolytica extract and terminated after 30 minutes by the
addition of 2 volumes of 1.25% FeCl3, 1 N HCl, 5% trichloroacetic acid. Product
formation was determined by the change in absorbance at 540 nm and comparison to an
acetyl phosphate standard curve. All assays were performed in triplicate.
Short hairpin RNA interference constructs
In order to knock down the expression of the ACK gene in E. histolytica via RNA
interference (RNAi), constructs were made using a two-step PCR procedure (Figure
5.2A) [10]. Constructs form short hairpin RNAs (shRNAs), each composed of a 29 base
sense strand, a 9 base loop, and a 29 base antisense strand (Figure 5.2C). To generate
shRNAs against the EhACK gene, four sequences were selected from the E. histolytica
ACK gene sequence using the siRNA target finder at
http://www.ambion.com/techlib/misc/siRNA_finder.html. Each sequence was denoted
according to its starting nucleotide position (441, 462, 600, and 842) within the EhACK
gene sequence. Chosen sequences contained 21 nucleotides, beginning with AA and
possessing GC content between 30 and 50 percent. A 29 nucleotide sequence was
generated by the addition of 8 nucleotides from the EhACK gene sequence by addition to
each 21 nucleotide sequence. A scrambled negative control sequence was generated by
inputting the experimental construct 441 sequence into a word scrambler
(http://www.lerfjhax.com/scrambler) to jumble the sequences. The scrambled control
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along with the other 29 nucleotide shDNA sequences were blasted against the E.
histolytica genome to ensure that there were no possible off-target effects.
The reverse primers for each round of PCR were designed using the reverse
complements of the desired constructs (Table 5.1). The reverse primer for the first round
of PCR contained the reverse complement of the 3’ end of the E. histolytica U6 promoter
(GGATAAAAAGAAAAATAAAATT), the ApaI site (GGGCCC), the sense strand of
the 29-mer shRNA sequence chosen with the siRNA target finder, and the 9 base loop
(TTCAAGAGA). The reverse primer for the second round of PCR contained the reverse
complement of the 9 base loop, the antisense strand of the shRNA sequence, the T6
terminator (TTTTTT), and the NotI site (GCGGCCGC). Because the shRNA sequence
ends in TT, only TTTT was inserted as the T6 terminator. Additionally, the reverse
complement of GATCGA was added to the end of the sequence to allow for optimal NotI
digestion.
The first round of PCR was conducted using KOD Hot Start DNA polymerase
(EMD Chemicals), along with the U6 HindIII forward primer
(CTACTGAAGCTTGTTTTTATGAAAAAGTGTATTTGC, 10 µM) and the first round
reverse primers (10 µM) (Table 5.1). pGIR310:U6 + PATscram (45µg/ml) plasmid
(kindly provided by Dr. William Petri [10]), containing the RNA polymerase III U6
promoter originally cloned from E. histolytica genomic DNA was used as the template.
Two 50 µl reactions were performed for each shRNA construct using 2 µl and 5 µl of
plasmid template, respectively, and the published PCR conditions [10]. Round 1 PCR
products were confirmed by gel electrophoresis.
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The second round of PCR was conducted using KOD Hot Start DNA polymerase,
along with the U6 HindIII forward primer (10 µM) and the second round reverse primers
(10 µM) (Table 5.1). Two 50 µl reactions were performed for each shRNA construct
using 2 µl of the respective Round 1 PCR products as the template and the published
PCR conditions [10]. Final PCR products from Round 2 were confirmed by gel
electrophoresis.
Final PCR products were purified used the Wizard SV PCR Clean-Up System
(Promega) and digested separately in two consecutive reactions with HindIII and NotI,
along with expression vector pGIR310: EV+PL (also known as pGIR310 2.1.2) an empty
vector pGIR310 modified with a HindIII-SalI-NotI-HindIII polylinker. After gelpurification of the digested products, the RNAi construct inserts were directly cloned into
pGIR310: EV+PL between the HindIII and NotI sites of the polylinker using Novagen 2x
clonables (EMD Chemicals) (Figure 5.2B).
Recombinant plasmids were transformed into NovaBlue competent E. coli cells
(Novagen, Inc.) and plated on LB-ampicillin plates. Proper ligation was confirmed by
PCR colony screen using the conditions described in the creation of shDNA sequences.
Transformed colonies were grown up into LB-ampicillin medium, and the recombinant
plasmids purified using the Zyppy Plasmid Miniprep Kit (Zymo Research Corporation).
Purified plasmids were digested with HindIII and NotI and run on an agarose gel for
further verification of proper RNAi construct insertion into pGIR310. Confirmed clones
were sequenced using the Sp6 forward primer and the hgl reverse primer by the Clemson
University Genomics Institute. Recombinant plasmids verified by sequencing to contain
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the correct shRNAi construct were produced and purified on a large-scale using Zyppy
Plasmid Maxiprep Kit (Zymo Research Corporation) or the Plasmids Mega Prep Kit
(Qiagen, Inc.).
Control Transfection Plasmids
The pGIR308 and pGIR209 plasmids were obtained from the laboratory of Dr.
Lesly Temesvari at Clemson University. These plasmids are used as part of a tetracycline
inducible system often used to express or over express modified proteins in E. histolytica.
The plasmid were obtained and transformed into NovaBlue (Novagen, Inc.) E. coli cells.
Plasmid was purified using a Plasmid Mega Prep Kit (Qiagen, Inc.).
Transfection of E. histolytica
Two separate methods of transfecting E. histolytica cells were utilized. For
electroporation cells were cultivated as described above. Cells grown to confluence were
washed twice using ice-cold phosphate buffered saline, and washed once with ice-cold
Cytomix (120 mM potassium chloride, 0.15 mM calcium chloride, 10 mM potassium
phosphate, 25 mM HEPES, 2 mM EGTA, 5 mM magnesium chloride, pH 7.6) [15]. The
cells were resuspended to a concentration of 1 x 106 cells/800 µL in freshly generated
Cytomix-AG (Cytomix containing 4 mM ATP and 10 mM glutathione). 1 x 106 cells
were placed in a 4 mm electroporation cuvette along with 200 µL of sterile water for
controls, or 60-80 µg of prepped plasmid RNAi constructs and pulsed twice at 1200 volts
+ 25 µFD using a Gene Pulser Xcell Total System, Model No. 165-2660 (BioRad, Inc.)
Time constants of 0.3-0.6 msec were routinely observed. The cells were immediately
returned to 50 mL sterile cell culture flasks containing pre-warmed media. The cells were
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incubated at 37°C in a water-jacketed incubator. Hygromycin or G418 were added at
concentration of 5-15 µg/mL and 3-6 µg/mL respectively where indicated after 24-72
hours.
For the alternative method of transformation, cells were cultivated as described
above. Cells grown to confluence were washed twice with phosphate buffered saline and
resuspended to a concentration of 1 x 106 cells/mL. 15 µL of Superfect® (Qiagen, Inc.)
reagent was added to 20-40 µg of plasmid and incubated at ambient temperature for 5-10
minutes to allow transformation complexes to form. The Superfect®-plasmid complex
added to either microcentrifuge tubes or 5 mL sterile glass vials along with 1 x 106 cells
and incubated horizontally at 37°C for 3-4 hours. Following the incubation, cells were
returned to 50 mL sterile flasks containing pre-warmed media and incubated at 37°C.
Antibiotics were added at concentration described above after 24-72 hours.
Generation of a hygromycin killing curve
1 x 106 cells were inoculated into 50 mL sterile flasks containing pre-warmed
media. Hygromycin was added at concentrations of 0, 2.5, 5, 10, 15, and 20 µg/mL in
equivalent volumes and incubated at 37°C. The cells were counted by light microscopy
using a hemocytometer every 24 hours over a period of 4 days. The data representing
cells counted after 48 hours was transformed to percent cells surviving and a smooth,
second order regression curve was generated using Kaleidagraph (Synergy Software).
Manual interpolation was used to determine the LD50.
Chemicals
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Chemicals were obtained from Sigma-Aldrich, ThermoFisher Scientific, or VWR
Scientific Products.
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Table 5.1. Reverse primer sequences to create shRNAi constructs.
EhACK
sequence
441
462
600
842
Scrambled
control
New
scrambled
control

Round 1 of PCR

Round 2 of PCR

TCTCTTGAACGTATGTTCTTTCTG
CTTGTGAGATGGTTGGGCCCAAT
TTTATTTTTCTTTTTATCC
TCTCTTGAATTTGGTAAGGTTGT
GGAATAGCGTATGTTGGGCCCAA
TTTTATTTTTCTTTTTATCC
TCTCTTGAACAATGCCACAACAA
CTAGAACCACTCGTTGGGCCCAA
TTTTATTTTTCTTTTTATCC
TCTCTTGAAACATGTTTTAGCTTT
TGGACCTCTAGTTTGGGCCCAAT
TTTATTTTTCTTTTTATCC
TCTCTTGAAGCTTCGTTATCTTCG
GTGTGATTGATGTTGGGCCCAAT
TTTATTTTTCTTTTTATCC
TCTCTTGAATATATTTATTTACCG
TTGAGTGGCCCTTTGGGCCCAAT
TTTATTTTTCTTTTTATCC

TCGATCGCGGCCGCAAAAAACCA
TCTCACAAGCAGAAAGAACATAG
CTCTCTTGAA
TCGATCGCGGCCGCAAAAAACAT
ACGCTATTCCACAACCTTACCAA
ATCTCTTGAA
TCGATCGCGGCCGCAAAAAACAG
GTGGTTCTAGTTGTTGTGGCATTG
TCTCTTGAA
TCGATCGCGGCCGCAAAAAAACT
AGAGGTCCAAAAGCTAAAACATG
TTCTCTTGAA
TCGATCGCGGCCGCAAAAAACAT
CAATCACACCGAAGATAACGAAG
CTCTCTTGAA
TCGATCGCGGCCGCAAAAAAAGG
GCCACTCAACGGTAAATAAATAT
ATCTCTTGAA
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Figure 5.2. shRNA system for Entamoeba histolytica. (A) Diagram of the two-step PCR
process for generating short hairpins shRNA constructs. Genomic DNA (or subsequently,
the cloned U6 promoter) was used as a template to amplify the E. histolytica U6 promoter
and to add the hairpins. The primers in the first PCR round were the forward primer,
containing a HindIII site and 5' end of the U6 promoter, and a first reverse primer,
containing the U6 promoter 3' end, the shRNA sense strand sequence, and the 9nucleotide loop. To yield the final product, in the second PCR round, the same forward
primer was used, with a second reverse primer containing the loop sequence, the
antisense strand sequence, the termination sequence, and a NotI recognition site, using
the first round product as a template. The primers used to generate the PCR products are
listed in Table 5.1. (B) PCR products were cloned into the HindIII and NotI sites.
pGIR310 confers hygromycin resistance in amoebae and ampicillin resistance in E. coli
bacteria. (C) Expected structure of 29-basepair shRNA before processing by Dicer The
29-basepair stem and 9-nucleotide loop are shown. Taken from [9].
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III. RESULTS
Acetate kinase operates preferentially in the direction of acetate synthesis
Native extracts of E. histolytica cultured cells only demonstrated PPi-forming
ACK activity in the acetate-forming (0.594 ± 0.005 µmol min-1 mg-1) direction. The
absence of observable activity in the acetyl phosphate-forming direction is likely due to
the low concentrations of enzyme isolated from the cells, a problem encountered upon
initial discovery of the enzyme more than 35 years ago [7]. This finding supports
previous work [8] on the recombinant E. histolytica ACK that the enzyme functions
physiologically in the direction of acetate/PPi formation. We were unable to detect an
ATP-dependent ACK activity when extracts were prepared axenically. An ATPdependent ACK activity was reported nearly 50 years prior, however cellular extracts
prepared were from xenically cultured E. histolytica cells [16].
PTA and XFP activities are absent in E. histolytica extracts.
Other eukaryotes that have ACK also have an ORF encoding one of two bacterial
partner enzymes. In the green algae Chlamydomonas and the oomycete Phytophthora, the
presence of a gene encoding PTA provides a pathway for the interconversion of acetate to
acetyl-CoA. A gene encoding XFP has been identified in all fungi that have an ACK,
allowing for the conversion of xylulose 5-phosphate and fructose 6-phosphate to acetate
in order to produce ATP as part of a modified pentose phosphoketolase pathway. The
absence of ORFs encoding PTA or XFP in the most recent E. histolytica genome
assembly indicates the possibility that either an XFP or PTA is in a region of the genome
that has not been assembled or a new class of XFP or PTA structurally different from the
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known bacterial enzymes is present. To rule out the presence of a PTA or XFP,
Entamoeba cell extracts were prepared and assayed for PTA and XFP activity. PTA
activity was not observed in the acetyl phosphate-forming or the acetyl-CoA-forming
direction. Likewise, XFP activity was not observed when assayed in the direction of
acetyl phosphate formation using fructose-6 phosphate as the substrate.
Problems with the RNA interference protocol in E. histolytica
Initial antibiotic selection for pGIR310 was performed using 15 µg/mL of
hygromycin. After unsuccessful transfection attempts using this antibiotic, a hygromycin
killing curve was generated (Figure 5.3). Manual interpolation of the curve indicated an
LD50 of approximately 1 µg/mL. Using 10X the LD50, a new concentration of 10 µg/mL
hygromycin was utilized for future experiments. Where half the antibiotic dose was to be
used, 5 µg/mL of hygromycin was used. This antibiotic selection was also utilized in the
last transformation for cells transfected with pGIR308. Utilizing half of the antibiotic
dose did not improve the experimental outcomes.
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Figure 5.3. Hygromycin killing curve generated using E. histolytica cultures. A LD50 of
approximately 1 µg/mL was extrapolated manually.
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We were unable to produce RNA interference with short hairpin RNAs using two
separate protocols due to problems with transfection. The first protocol involves the use
of electroporation, thereby damaging the cell membranes and encouraging the uptake of
plasmids. The method was attempted three times with similar results. On each occasion,
with one exception, cells that were electroporated were returned to media and began to
divide normally until the addition of antibiotics. During one trial all cells that were
electroporated failed to survive the 24 hour recovery period. Cells that survived
electroporation were allowed to recover for 24, 48, or 72 hours. For cells transfected with
pGIR310 or pGIR308 plasmids (60 µg, 80 µg, or 100 µg), 10µg/mL or 15 µg/mL of
hygromycin was added to the cells. In each case after 24 hours all cells containing 15
µg/mL of hygromycin did not survive. When 10 µg/mL of hygromycin was employed the
transfected cells survived 24-48 hours. Cells transfected with pGIR209 were selected for
using 3 µg/mL or 6 µg/mL of G418. Cells selected with 6 µg/mL of G418 did not survive
more than 24 hours. Cells selected with 3 µg/mL of G418 survived only 48-72 hours.
A second protocol involving the use of the commercial transfection reagent
Superfect® was employed after the electroporation attempts. Superfect® reagent allows
for the formation of vesicle transformation complexes which have been used previously
[9, 10] to successfully transfect E. histolytica cells. In this procedure, cells are incubated
with pre-formed transformation complexes and allowed to naturally endocytose the
plasmid. This process is thought to be advantageous over the electroporation procedure in
that recipient cell competency is not lost due to directed damage to the cell membranes.
Researchers utilizing this protocol for E. histolytica transfection have reported a higher
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success rate than transfection by electroporation (personal communication, Dr. Upinder
Singh and Dr. Richard Pearson, Stanford University).
The Superfect® transformation protocol was attempted on four separate occasions
without success. In each case, 20 µg of plasmid DNA was transfected with a contact
incubation time of three or four hours. Antibiotics employed for selection were added
after 48 or 72 hours at concentrations of 10 µg/mL or 5 µg/mL of hygromycin for
pGIR310 series or pGIR308 plasmids and 6 µg/mL or 3 µg/mL of G418 for cells
transfected with the pGIR209 plasmid. Concentrations of 5 µg/mL of hygromycin and
3µg/mL G418 or half the antibiotic dosing concentrations were utilized in the last
transformation attempt to encourage cell growth during selection. Cells receiving full
doses of hygromycin (10 µg/mL) or G418 (6 µg/mL) did not survive more than 48 hours.
During the last transformation where half concentrations of antibiotics were utilized (5
µg/mL hygromycin and 3 µg/mL G418) the cells transformed with plasmids survived up
to 96 hours, but were inconsistent with the constructs transformed. The cells that survived
transformation were very small in quantity (25-50 living, motile cells) after 48 hours.
While some of these cells continued to survive, the cells doubled only once in another 48
hours resulting in very small cells numbers that did not survive more than 96 hours. One
exception was the flask containing cells that were incubated with Superfect® and no
plasmid, but did contain 5 µg/mL of hygromycin. Despite the addition of antibiotics this
culture continued to divide and increase the rate of doubling after 72 hours. By 96 hours
10 colonies containing more than 200 cells were observed.
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IV. DISCUSSION
The PPi-dependent ACK found in E. histolytica offers a unique opportunity to
investigate the physiological roles of this novel enzyme. All of the other known ACKs
found in all other eukaryal, bacterial, and archaeal organisms utilize ATP as a phosphoryl
donor [4, 17, 18]. Phylogenies constructed using eukaryotic ACK sequences also support
the novelty of this enzyme, as Entamoeba ACKs form a clade separate from the other
eukaryotic ACKs [4].
As previously mentioned, E. histolytica lacks ORFs [8] for PTA and XFP, the
partners for ACK found in other eukaryotes that have an ACK. Furthermore, E.
histolytica lacks the genes for other potential partner enzymes which are found in other
organisms (Figure 5.4). However, the absence of these enzymes does not preclude the
possibility that an evolutionarily distinct PTA or XFP is present in the parasite. We were
unable to detect PTA and XFP activities in E. histolytica cellular extracts. The absence of
bacterial ACK partner enzymes in Entamoeba suggests that a novel acetyl phosphate
generating enzyme is the partner for the PPi-ACK in this protist. While the identification
of this partner enzyme remains unknown, E. histolytica possesses a complete pentose
phosphate pathway, but lacks a mitochondrion, and therefore TCA cycle. A novel partner
enzyme could generate acetyl phosphate from an intermediate of the pentose phosphate
pathway or the end product of a yet to be identified catabolic pathway.
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Figure 5.4. Network of pathways involved in the metabolism of acetyl-CoA. Pathways in
green have been identified in Entamoeba histolytica, while pathways in gray have been
observed in species other than E. histolytica. Acetate kinase (ACK) functions in the
interconversion of acetate and acetyl phosphate. E. histolytica specifically utilizes a PPidependent ACK, which differs from the ATP-dependent ACK found in prokaryotes and
archaea. To date, there are no known partner enzymes for PPi-dependent ACK in E.
histolytica.
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Preferentially operating in the direction of acetate formation, the E. histolytica
ACK could provide PPi which can be utilized by phosphofructokinase (PPi-PFK) and
PPi-dependent phosphoenolpyruvate dikinase (PPDK) in glycolysis during substrate-level
phosphorylation; the primary source of energy for the parasite (Figure 5.5). Further
evidence supporting this physiological role includes previous observations of acetate
fermentation by the parasite [19]. Microarray data also indicates the presence of acetate
kinase transcripts in both cyst and trophozoite life stages of the parasite [20]. However,
an unknown enzyme partner must exist in order to synthesize acetyl phosphate from an
intermediate in pentose phosphate pathway or another metabolic process (Figure 5.6).
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Figure 5.5. Proposed metabolic pathway(s) for acetate synthesis and utilization in E.
histolytica. An extended glycolytic pathway is present in E. histolytica in which pyruvate
is converted to acetyl-CoA by the PFOR. Acetyl-CoA can then be converted to acetate by
and ADP-ACS or by a ACK/PTA pathway. HK, hexokinase; PPi-dependent
phosphofructokinase, PPi-PFK; 3-PGK, 3-phosphoglycerate kinase; PPDK,
phosphoenolpyruvate dikinase; HYD, hydrogenase; PFOR, pyruvate ferrodoxin
oxidoreductase; ADP-ACS, ADP-forming acetyl-CoA synthetase; phosphotransacetylase,
PTA; acetate kinase, ACK.
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Figure 5.6. Proposed metabolic pathway(s) for PPi synthesis and utilization in E.
histolytica. An extended glycolytic pathway is present in E. histolytica in which glucose
is converted to acetyl-CoA utilizing PPi-dependent enzymes. Acetyl-CoA can then be
converted to acetate by an ADP-ACS. Glucose 6-phosphate can enter the pentose
phosphate pathway in order to generate acetyl phosphate from an unknown intermediate
and unknown enzyme partner. Other unknown enzyme partners could be utilized to
generate acetyl phosphate from unknown sources. PPi-dependent phosphofructokinase,
PPi-PFK; 3-PGK, 3-phosphoglycerate kinase; PPDK, phosphoenolpyruvate dikinase;
ADP-ACS, ADP-forming acetyl-CoA synthetase; acetate kinase; PPi-ACK.
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Our attempts at transfections to perform RNA interference in E. histolytica were
unsuccessful. In all experimental trials, cells transformed with plasmids containing the
scrambled sequences did not survive any longer than cells transfected with plasmids
capable of coding for shRNAs. Should ACK be essential for the survival of E. histolytica,
we would expect that the parasites would not survive selection. In this case, an alternative
inducible RNA interference system could be constructed. A tetracycline inducible system
has already been employed in E. histolytica [21, 22] and could be modified to serve this
purpose.
Alternatively to an essential role in parasite metabolism, ACK may play an
important role in other cellular processes whose disruption could impede growth and
replication. Quantitative reverse transcriptase PCR (qRT-PCR) can be utilized to examine
RNA levels of the scrambled control against the experimental constructs to determine
ACK gene expression is actually being knocked down by RNA interference. ACK assays
can also be employed to detect enzyme activity.
Treatment for infection by E. histolytica involves the administration of two drugs.
Metronidazole (Flagyl), a nitromidazole which interacts with protozoal ferrodoxin (PFOR
reaction in Figure 5.3) to produce toxic byproducts is used to treat invasive trophozoites,
and paromomycin (Humatin) an aminoglycoside, is used as a luminal amoebicide [23]. In
vitro amoebic resistance to metronidazole and in vivo cytotoxic and nephrotoxic effects
from paromomycin indicates a need for the identification of novel drug targets in this
parasite. Should the PPi-dependent ACK be essential to the organisms survival, further
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research regarding this novel enzyme as a possible drug target for E. histolytica infection
should be pursued.
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CHAPTER VI
CONCLUDING REMARKS AND FUTURE PROSPECTS
Entamoeba histolytica possesses a novel PPi-dependent acetate kinase (ACK).
This is the first PPi-dependent ACK to be biochemically and kinetically characterized and
is the only known member of the ASKHA superfamily that can utilize PPi. The enzyme
operates preferentially in the direction of acetate/PPi synthesis and is capable of utilizing
acyl substrates as long as hexanoate in the direction of acetyl phosphate synthesis. The
kinetic parameters for substrate affinity indicate that the enzyme functions as both an
acetate and propionate kinase in the acetyl phosphate-forming direction; however, the
low kcat raises question whether this direction of the reaction is physiological. Studies of
the mechanism of this enzyme indicates that the PPi-ACK follows a sequential
mechanism, supporting a direct in-line phosphoryl transfer mechanism previously
reported in the most well characterized ATP-dependent ACK found in Methanosarcina
thermophila.
A modified hydroxamate assay was developed for measuring the synthesis of
acetyl phosphate to overcome problems associated with using multiple coupled enzymes
to detect ACK activity. The assay can be used to detect ACK activity of both ATPdependent and PPi-dependent acetate kinases in the direction of acetyl phosphate
synthesis. Modifications of this assay may be used for other enzymes that utilize acetyl
phosphate or acetyl-CoA as a substrate, such as ACS, ADP-ACS, or PTA.
Although a number of conserved catalytically important residues are present in
the E. histolytica PPi-ACK, this investigation revealed a number of significant active site
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changes in comparison to the well characterized M. thermophila ATP-dependent ACK.
The residues His117, His172, Val87, Thr201, Thr15, Arg274, and Asp272 appear to be essential
for catalysis in the direction of acetate synthesis. Furthermore, His117 appears to be
critically important for binding acetyl phosphate and therefore important in acetate/PPi
synthesis reactions. While Thr15 of the E. histolytica ACK appears to lie outside of the
active site, the residue was implicated in catalysis. For this process to occur, the residue
would need to be brought into the active site for substrate interaction. Therefore a logical
proposition is that the E. histolytica ACK active site undergoes a claw-like closure; a
process also observed in the M. thermophila ACK. Closure of the active site would also
bring Thr15 into close proximity with Arg274 which is also implicated in catalysis. The
active site of the E. histolytica ACK also lacks the adenosine pocket present in the ATPdependent, M. thermophila ACK.
Based on the results presented in this dissertation, the data supports the hypothesis
that the E. histolytica ACK operates physiologically in the direction of PPi synthesis. PPi
generated from this reaction may be utilized by the glycolytic enzymes PPi-dependent
phosphofructokinase (PPi-PFK) and PPi-dependent phosphoenolpyruvate dikinase
(PPDK) in substrate-level phosphorylation for energy generation by the parasite.
RNA interference of E. histolytica ACK was unable to be carried out due to
problems with transfection of plasmid DNA into the parasite. However, data garnered
from cellular extracts indicates the presence of the PPi-dependent ACK, and absence of
an ATP-dependent ACK activity. Utilization of PPi by PPi-dependent glycolytic enzymes
produced by the parasite’s ACK suggests an important role for this enzyme in
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Entamoeba’s metabolism. Prokaryotic ACK partner enzyme activities of
phosphotransacetylase (PTA) and xylulose 5-phosphate/fructose 6- phosphate
phosphoketolase (XFP) were absent in parasite cellular extracts. The absence of bacterial
ACK partner enzymes in Entamoeba suggests that a novel acetyl phosphate generating
enzyme is the partner for the PPi-ACK in this protist. A novel partner enzyme could
generate acetyl phosphate from an intermediate of the pentose phosphate pathway or the
end product of a yet to be identified catabolic pathway. Identification and
characterization of the Entamoeba PPi-ACK partner enzyme will provide unique insights
into the metabolism of this important protist.
This study has provided significant knowledge on a novel PPi-dependent ACK,
and helps gain a better understanding of ACKs and the ASKHA enzyme superfamily.
Future experiments investigating additional active site residues will assist in the
understanding of the overall mechanism of this novel ACK. Continued research on the
ack RNA knockdown may lead to a better understanding of the essentiality of this
enzyme in E. histolytica physiology, and the possibility of identifying new drug targets
for the treatment of amoebiasis.
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